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ABSTRACT 
Cyclophilin A (CypA) is the well-studied member of a group of ubiquitous and evolutionarily con-
served families of enzymes called peptidyl–prolyl isomerases (PPIases). These enzymes catalyze the cis-
trans isomerization of peptidyl-prolyl bond in many proteins. The distinctive functional path triggered by 
each isomeric state of peptidyl-prolyl bond renders PPIase-catalyzed isomerization a molecular switch-
ing mechanism to be used on physiological demand. PPIase activity has been implicated in protein fold-
ing, signal transduction, and ion channel gating as well as pathological condition such as cancer, Alz-
heimer’s, and microbial infections.  
The more than five order of magnitude speed-up in the rate of peptidyl–prolyl cis–trans isomeri-
zation by CypA has been the target of intense research. Normal and accelerated molecular dynamic sim-
ulations were carried out to understand the catalytic mechanism of CypA in atomistic details. The results 
reaffirm transition state stabilization as the main factor in the astonishing enhancement in isomerization 
rate by enzyme. The ensuing intramolecular polarization, as a result of the loss of pseudo double bond 
character of the peptide bond at the transition state, was shown to contribute only about −1.0 kcal/mol 
to stabilizing the transition state. This relatively small contribution demonstrates that routinely used 
fixed charge classical force fields can reasonably describe these types of biological systems. The compu-
tational studies also revealed that the undemanding exchange of the free substrate between β- and α-
helical regions is lost in the active site of the enzyme, where it is mainly in the β-region. The resultant 
relative change in conformational entropy favorably contributes to the free energy of stabilizing the 
transition state by CypA. The isomerization kinetics is strongly coupled to the enzyme motions while the 
chemical step and enzyme–substrate dynamics are in turn buckled to solvent fluctuations. The chemical 
step in the active site of the enzyme is therefore not separated from the fluctuations in the solvent. Of 
special interest is the nature of catalysis in a more realistic crowded environment, for example, the cell. 
Enzyme motions in such complicated medium are subjected to different viscosities and hydrodynamic 
properties, which could have implications for allosteric regulation and function. 
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1 
1  INTRODUCTION 
1.1 Peptidyl-Prolyl Isomerases (PPIases) 
The versatile nature of enzymes and their essential role in many vital biological processes have 
long been characterized (1, 2). It is well known that in addition to environmental factors, the functionali-
ty of an enzyme is intricately tailored to the nature of its targeted substrate (3, 4). The same is true for 
the catalysis of cis-trans isomerization of proline-containing proteins (5, 6). Although nonproline cis-
peptide bonds (ω-bonds) have been observed in 5–6% of protein crystal structures(7), proline is the 
most distinguishable amino acid that can readily adopt both cis and trans isomers. This is due to the 
small free energy difference between the two configurations of peptidyl-prolyl bond (8). Proline-
containing proteins therefore have the possibility of adopting different conformational states with 
distinctive regulatory role in many essential biological processes, such as protein folding(9), ion channel 
gating(10), and signal transduction(11). 
However due to a high free energy barrier of approximately 20 kcal/mol, the peptidyl-prolyl cis–
trans isomerization is inherently slow with a rate in the order of tens to hundreds of seconds(12, 13). 
Fortunately, the rate of these important processes are enhanced by more than five orders of magnitude 
through the catalytic action of a group of ubiquitous and evolutionarily conserved enzymes called 
peptidyl–prolyl isomerases(PPIases)(14). 
Four structurally unrelated families of PPIases include Cyclophilins (Cyps), FK506-binding pro-
teins (FKBPs), parvulins, and PTPA (15-19). Cyclophilins can be found in most cells of different tissues of 
all organisms (15). All cyclophilins have a common domain of approximately 109 amino acids(the cyclo-
philin-like domain) and a second domain unique to each member of the family (15). There are 17 cyclo-
philins in the human genome with Cyclophilin A (CypA) as the well-studied member of this family(20). 
2 
The structure and physiological characteristics of CypA (the target of our study) are discussed in more 
details in Section 1.3.  
FKBPs have been also found in many different organisms. All FKBP domains share a structure of 
five stranded anti-parallel β-sheet with a short α-helix (21). Parvulins are small peptidyl-prolyl cis/trans 
isomerases, which show a typical βαααβαββ folding topology and a group of highly conserved residues 
(22). Pin1, the well-studied member of parvulin family, contains a WW binding and a PPIase domains 
that specifically catalyzes the phosphoserine/threonine-proline  motifs in different protein 
substrates(23). This substrate specificity provides a double regulatory mechanism of post-translational 
phosphorylation and conformational switching involved in Pin1 function(24). 
Phosphotyrosyl phosphatase activator (PTPA), the recently discovered member of PPIases family 
represents a well-conserved protein that has been found in a wide range of organisms from yeast to 
human (18). In contrast to monomeric cyclophilins, FKPBs and parvulins with a central beta-sheet,  the 
active site of PTPA is located at the interface of a substrate-induced dimer in an all-alpha-helix fold cata-
lytic domain(8). The regulatory role of PPTA is thought to be through reactivation of the protein phos-
phatase 2 (18).  
1.2 PPIases as Molecular Switch 
The distinctive functional path triggered by each isomeric state of peptidyl-prolyl bond renders 
PPIase-catalyzed isomerization a molecular switching mechanism to be used as a regulatory mechanism 
in both physiological and pathological condition(8). Some examples of these important features of PPI-
ases are summarized in following sections. 
1.2.1 Physiological Role of PPIases 
Cell Signaling: The appropriate timing and amplitude of signaling pathways are critical for the ef-
ficient functionality of the complicated network of biological processes. Extensive studies have proven 
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the role of PPIases in different signaling pathways of intra and extra cellular processes. For instance, the 
critical role of Pin1 in phosphorylation-specific prolyl isomerization for amplifying the Neu-Raf-Ras-MAP 
kinase pathway on multiple levels has been well studied(25).  
Neuron Activity: The higher abundance of Cyclophilins and FKBPs in the brain than in the im-
mune system signifies their critical role in the neuronal activities(26). It has been shown that FKBP52 
catalyze cis/trans isomerization of some areas of  TRPC1 implicated in controlling channel opening(27). 
FKBP52 controls the TRPC1 gating through isomerization, which in turn is required for turning of neu-
ronal growth cones to netrin-1 and myelin-associated glycoprotein and for axon guidance of commissu-
ral interneurons in the growing spinal cord(27).  
Immune response: The discovery of inhibition of CypA and FKBP families by immunosuppressive 
drugs CsA and FK506 sparked the initial interest in the possible regulatory role of peptidyl-prolyl isomer-
ization in the immune system. However, it was soon realized that PPIase activity is not involved in im-
munosuppression mechanism by these drugs.  Nevertheless, later discoveries showed that PPIases have 
themselves specific and important role in the immune system responses. Increasing number of evidenc-
es has established the regulatory role of Pin1 in the immune system. For instance, interferon-regulatory 
factor 3 (IRF3), the factor responsible for the establishment of innate immunity in response to either 
viral or microbial infection is negatively regulated by Pin1(28). It has been shown that inhibition of Pin1 
by RNA interference or genetic deletion resulted in enhanced IRF-3-dependent production of interferon-
beta, and finally the reduction of virus replication(28).  
Cell Cycle: There are extensive studies on Pin1 regulatory role in different levels of cell cycle in a 
wide range of cells and organisms (29, 30). For instance, a study on human cells and Xenopus extracts 
showed direct interaction of  Pin1 with a group of mitotic phosphoproteins in a way that is both 
phosphorylation-dependent and mitosis-specific (31). These Pin1-binding proteins include the repre-
sentative mitotic regulators Cdc25 and Cdc27(31).  
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Gene expression: PPIases activity is also implicated in different levels of gene expression includ-
ing phosphorylation-dependent peptidyl-prolyl isomerization with Pin1 and Phosphorylation-
independent isomerization by CypA and FKBPs(25). One of the studied examples is Fpr4, a member of 
the FK506 binding protein family in Saccharomyces cerevisiae, which catalyzes the proline isomerization 
of histones H3 in vitro(32). This enzyme binds the amino-terminal tail of histones H3 and H4 and cata-
lyzes the isomerization of H3 proline in vitro. It is shown the isomerization by Fpr4 inhibits the ability of 
Set2 to methylate H3 K36 in vitro. These findings imply that the conformational state of proline, con-
trolled by Fpr4, is important for methylation of H3K36 by Set2(32). Also, further studies suggest that ab-
rogation of Fpr4 catalytic activity in vivo results in increased levels of H3K36 methylation and delayed 
transcriptional induction kinetics of specific genes in yeast(32).  
1.2.2 PPIases and Pathogenesis 
As mentioned earlier, the molecular switching mechanism triggered by PPIases activity is in-
volved in an extremely interrelated network of physiological pathways.  It is therefore not surprising that 
any irregularly in the enzymatic activity of PPIases would result in a wide range of pathogenic condition. 
Some instances of diseases related to CypA activity will be discussed in Section 1.3.  
As for Pin1 and FKBP’s, the pathological activity of these enzymes is also implicated in many dif-
ferent diseases. For instance Increasing numbers of studies indicated overexpressed level of Pin1 in 
many human cancers such as breast and brain tumors as well as cancer of the prostate, lung, ovary, cer-
vical, and melanoma(33). High expression levels of FKBP family have been also reported in human can-
cer tissues compared to non-tumour samples. These include the high expression or down-regulation of 
FKBP51 in glioma, lymphoma and melanoma as well as pancreatic and colorectal cancer(34). 
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1.3 Human Cyclophilins  
1.3.1 General Features of Human Cyclophilins 
Cyclophilins have been found in mammals, plants, insects, fungi, and bacteria (15). They are 
structurally conserved throughout evolution and all have PPIase activity. There are 17 isoforms of cyclo-
philins in the human genome, but the function of most of them is unknown(20).  
All Cyclophilins share a common fold architecture consisting of eight antiparallel β sheets and 
two α-helices that pack against the sheets(15). The active site of the cyclophilin family consists of 
catalytic arginine and a highly conserved set of hydrophobic, aromatic, and polar residues including 
Phe60, Met61, Gln63, Ala101, Phe113, Trp121, Leu122, and His126(20). These residues constitute a 
binding surface along the PPIase domain of approximate 10 Å along the Arg55–His126 axis and 15 Å 
along the Trp121–Ala101 axis(20). Most of these residues are well conserved across all PPIase domains 
and participate in enzyme catalytic activity or substrate and inhibitor binding(20). A study on 15 of 17 
members of Human cyclophilin revealed that regions of the isomerase domain outside the proline-
binding surface have isoform specificity for both in vivo substrates and drug design(20). The study 
suggested  that this  site of diversity may be exploited for the development of selective ligands for each 
isoform(20).  
1.3.2 Human Cyclophilin A (CypA)  
The 18-kDa Cyclophilin A is the first member of the Cyclophilin family to be identified in mam-
mals (15). Interestingly, the purification of CypA from bovine thymocytes as an intracellular protein did 
not coincide with its identification as a protein with PPIase activity (15). Only five years later it was 
demonstrated that the protein with PPIase activity and cyclophilin A are indeed the same. CypA is a 
cytosolic protein that is present in all tissues of mammals and constitute up to 0.1–0.6% of the total cy-
tosolic proteins (35). However, other Cyclophilins are found in the endoplasmic reticulum (ER), the mito-
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chondria, or the nucleus (15). CypA is the main target of the immunosuppressive drug cyclosporine 
(CsA), a cyclic 11-amino-acid peptide that was initially isolated from the fungus Tolypocladium infla-
tum(15). Cyclosporine A binds and inhibits CypA with an IC50 value of 19 nM(36). 
1.3.3 CypA Structure 
CypA is a single domain protein of 165 residues with a globular structure dimensions of approx-
imately 34 x 33 x 30 Å (37, 38). It consists of an eight-stranded antiparallel β-barrel structure, with two α 
helices flanked each side of the barrel (37)(Figure 1). Two a-helices and eight beta-strands create a 
compact hydrophobic core with residues Val-6, Phe-8, Val-20, Phe-22, Leu-24, Phe- 36, Leu-39, Tyr-48, 
Phe-53, Ile-56, Leu-98, Met-100, Phe-112, Ile-114, and Phe-129(37).  
A pocket contains several conserved hydrophobic, and polar residues construct the binding site 
of CsA and other substrates in one side of the hydrophobic core (37).  Residues in this pocket include 
His-54, Arg-55, Ile-57, Phe-60, Met-61, Gln-63, Asn-102, Gln-111, Phe-113, Trp-121, Leu-122, Lys-125, 
and His-126(37). 
 
Figure 1 The structure of Human Cyclophilin A (CypA) (From Ref 38) 
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1.3.4 Physiological roles of CypA 
CypA with (kcat/Km) of about 16 μM−1 s−1 has been shown to play critical role in many physiologi-
cal processes including: 
Ion Channel Gating: 5-Hydroxytryptamine type 3 (5-HT3) receptors are members of the Cys-loop 
receptor superfamily (39). Neurotransmitter binding in these proteins triggers the opening (gating) of an 
ion channel by means of conformational change. Studies have shown that a specific proline between the 
two transmembrane helices of 5-HT3 can associate  binding to gating through a cis–trans isomerization 
of the protein backbone(40). Studies on several Proline analogues demonstrate a strong correlation  be-
tween the cis–trans energy gap and the activation of the channel(40). The observation suggests that 
CypA-catalysed cis–trans isomerization of this single proline provides the switch that makes conversion 
between open and closed states of the channel(40).  
Signaling: The interleukin-2 tyrosine kinase (Itk) participates in the intracellular signaling events 
leading to T cell activation(41). It is shown that the Itk catalytic activity is regulated  by the peptidyl-
prolyl isomerase activity of cyclophilin A(42). CypA forms a stable complex with  Itk in  T cells that is dis-
rupted by cyclosporine administration(42). 
The Itk conformational heterogeneity is induced by isomerization of Asn-286–Pro-287 peptide 
bond which its isomerization state plays the key role in regulating ligand selection. The cis and trans 
states of Asn-286–Pro-287 peptide bond bind different ligands which in turn trigger different signaling 
pathways and physiological processes(42). 
Intracellular trafficking: In the course of programmed cell death (apoptosis), the apoptosis-
inducing factor (AIF) moves from mitochondria to nuclei and finally contribute to the execution of cell 
death(43). Studies have  shown that lethal translocation of AIF to the nucleus requires interaction with 
CypA, suggesting a model in which two proteins that normally reside in separate cytoplasmic 
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compartments acquire novel properties when moving together to the nucleus(43). In vivo studies 
demonstrate that elimination of CypA indeed affords the neuroprotection in vivo(43).  
1.3.5 Pathological condition by CypA  
In addition to playing critical role in many important physiological processes, the peptidyl-prolyl 
isomerase activity of CypA is also implicated in various pathological condition and diseases. Below some 
examples of the pathological condition involving CypA are summarized. 
Viral Infection: CypA has been shown to have a critical role in the human immunodeficiency vi-
rus type 1(HIV-1) infectivity (44). Extensive studies have shown that HIV-1 binds CypA via Gly89-Pro90 
peptide of the flexible and exposed loop within the N-terminal domain of the structure called cap-
sid(45). Capsid is the protein which forms the virion core and assembles into a cone enclosing the viral 
RNA. During the viral life cycle, the viral genome and related enzymes enter host cell and organized and 
packaged through capsid assembling and disassembling(46). Only viruses with the mature capsids can 
infect other host cells. The conformational changes necessary for capsid assembly and disassembly are 
shown to be through the CypA-catalysed cis-trans isomerization of the peptidyl-prolyl bond in cap-
sid(47). As a result of this interaction, CypA is packaged into HIV-1 virions during viral replication at a 
molar ratio of 1:10 CypA/CA(48). Mutation of either G89 or P90 or addition of immunosuppressive drug 
cyclosporine A (CsA) prevents CypA packaging into HIV-1 virions leading to the formation of non-
infectious particles(49).  
In addition to HIV-1 infectivity, CypA is also implicated in other viral infections including hepatitis 
C virus (HCV), hepatitis B virus (HBV), influenza A virus, respiratory syndrome coronavirus (SARS-CoV), 
and cytomegalovirus (HCMV)(35). 
Cancer: CypA has been proposed as a biomarker for certain cancer subtypes because the CypA 
expression levels have been shown to correlate with progression of different types of tumor (50). CypA 
is thought to act via different pathological mechanisms including increased cell proliferation, blockage of 
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apoptosis, malignant transformation, and metastasis (50). CypA is implicated in different kinds of cancer 
including small cell lung cancer, pancreatic and breast cancer as well as squamous cell carcinoma, glio-
blastoma multiforme, and melanoma (50). 
Degeneration of Nervous System: The pathological function of CypA is also detected in neuro-
degenerative diseases such as Alzheimer and Amyotrophic lateral sclerosis (ALS)(35).  
One study showed that CypA-driven activation of a pro-inflammatory pathway in the brain de-
termines the release of neurotoxic molecules from the vessels, damaging neurons and their connections 
(35). It is also shown that the CD147 receptor, by interacting with CypA, can influence amyloid-β peptide 
levels, a protein that is important in developing Alzheimer’s disease (35).  
Other diseases: Increasing number of studies demonstrated the role of CypA in various types of 
cardiovascular diseases such as Atherosclerosis and Abdominal aortic aneurysm (35). The increased level 
of CypA malfunction is also implicated in Rheumatoid Arthritis, Periodontitis, Asthma, aging and diabe-
tes (35). 
1.3.6 Cyclophilin A Inhibitors  
The most studied and tightest binding ligand of CypA, cyclosporine A (CsA) binds CypA and inhib-
its its catalytic activity (35). However, the widespread use of CsA as an immunosuppressant in transplan-
tation has shown multiple side effects such as severe nephrotoxicity(35). Due to the side effects of CsA 
there is now a great interest in developing compounds that selectively inhibit CypA without immuno-
suppressive effects. In this regard, it is shown that isoenzyme specific inhibitors would probably lack cal-
cineurin-binding properties and, therefore, has fewer side effects than a CsA(35). Examples of these 
non-immunosuppressive analogues of CsA are Alisporivir with anti-viral effect and NIM811 that has 
shown anti-inflammatory effects in acute lung injury and arthritis (35). 
Finding CypA inhibitors with capacity to target specific functions of CypA, while leaving other 
functions unaffected is current main challenge in developing CypA inhibitors(35). MM218 is an example 
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of such inhibitors that while selectively inhibit the extracellular fraction of CypA with a stronger anti-
inflammatory effect than CsA, has shown no detectable adverse effects in animal samples (35). 
1.3.7 Suggested Mechanisms for CypA-Catalysed Isomerization 
The origin of the highly accelerated rate of more than five orders of magnitude in isomerization 
of a peptide substrate by CypA has been attributed to different mechanisms including: 
Nucleophilic attack: It was initially proposed that the astounding rate enhancement of peptidyl-
prolyl isomerization by CypA can be explained by a nucleophilic attack mechanism (51). The nucleophilic 
groups on the enzyme (e.g. cysteine) can attack the carbonyl carbon atom of the residue preceding Pro-
line. This results in the collapse of pseudo-double bond of the peptide bond and formation of a tetrahe-
dral intermediate. The easier rotation around the peptide bond compared to pseudo-double bond re-
duces the activation energy barrier that finally results in the rate enhancement. However, the purified 
mutant proteins with no nucleophilic groups were shown to retain full affinity for cyclosporine A and 
equivalent catalytic efficiency as a peptidyl-prolyl isomerase (36). Therefore, the nucleophilic groups in 
enzyme play no essential role in catalysis. 
 Bond distortion: The distortion of peptidyl-prolyl amide bond is also suggested as an alternative 
mechanism of CypA-catalysed isomerization(52). According to this mechanism, although the amide 
resonance stabilization favours the planarity of the prolyl peptide bond, the thermal motions of the 
peptide bond at ambient temperature distort the peptide bond up to ±20° without significantly 
increasing the energy. The population of these 20° distorted ground state is therefore increased via hy-
drogen bonding with enzyme Asn102 while developing another H-bond with Arg55 guanidinium group. 
This later H-bonding stabilizes the lone pair on the amide nitrogen which finally results in weakening of 
pseudo-double peptide bond(52). 
Substrate desolvation: Previous studies have shown that the weakening of the pseudo-double-
bond character of C−N in nonaqueous environment of PPIase acƟve site resulted in a small reduction of 
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the isomerization barrier height by about 1.3 kcal/mol(53). Likewise, a small decrease in the barrier 
height by about 1.8 kcal/mol with a resulting speedup of up to 20-fold was observed for the rate of 
cis−trans isomerizaƟon in micelles (54, 55). In addition, molecular dynamics simulations in the absence 
of explicit water molecules around the prolyl peptide bond have shown an increase in the rate of 
cis−trans isomerizaƟon (56). The speedup is due to a reduction in the effective roughness on the energy 
landscape that results in a change in the kinetic prefactor and, therefore, the rate of isomerization (56).  
The role of enzyme dynamics: An example of the role of enzyme dynamics in the catalytic action 
of CypA is illustrated in the work of Fraser et al.(57). Using ambient temperature X-ray crystallography 
and NMR relaxation experiments a less active CypA mutant was studied. The study concluded that the 
reduction in catalytic rate was due to interruption of the motions that are involved in the interconver-
sion of the substrate. However, other studies ruled out the enzyme dynamics involvement in chemical 
step during catalysis. The controversy over the role of enzyme dynamics will be discussed in more detail 
in chapter 4. 
Transition State Stabilization: Although each of the mechanisms mentioned above can rational-
ize some of the catalytic activity of CypA, none of them can quantitatively explain the observed high 
isomerization speed-up in the presence of the enzyme. However, the transition state stabilization mech-
anism has been shown to reasonably describe the observed rate enhancement of peptidyl-prolyl isomer-
ization by CypA (55). The free energy landscape, which represents the energetic interplay between sub-
strate and enzyme during the isomerization, can provide mechanistic clue to the catalytic action of 
CypA. In chapter 3 the mechanism of transition state stabilization of CypA-catalyzed isomerization will 
be discussed in more details.  
1.4 Research Aims and Approach in Present Work  
Considering the wide range of CypA physiological and pathological roles, understanding the de-
tails of its action in the human body is critical. Many experimental studies have been carried out on PPI-
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ases and enzyme mechanism, in general. However, there are certain levels of atomic details that are still 
not accessible using current experimental techniques. In this regard, Molecular Dynamics (MD) simula-
tion methods are promising and complementary to experiments in investigating the biomolecular pro-
cesses at atomistic detail and with respect to their dynamic nature. 
In the present work, using a combination of conventional and accelerated molecular dynamics 
simulation, we investigated the involving interactions, dynamics, and solvent effects in the catalytic 
mechanism of Cyclophilin A as a model system to understand the intricacies of enzyme catalysis. Accel-
erated MD allowed us to observe the cis-trans interconversion in the catalyzed and uncatalyzed isomeri-
zation processes in explicit water. We aimed to detect and elaborate the underlying network of energet-
ic interactions and dynamic coupling between substrate and enzyme that result in astonishing rate 
enhancement of peptidyl-prolyl cis to trans isomerization. The effects of solvent dynamics on isomeriza-
tion kinetic and its implication for obtaining accurate isomerization kinetics in actual biological environ-
ment were also examined.  
 Our results show configurational-sensitive interactions and strong coupling between enzyme 
dynamics and chemical step, which is also intricately affected by solvent dynamics. The results highlight 
the importance of configurational state and dynamical contributions from enzyme and solvent in cata-
lyzed peptidyl-prolyl isomerization. The results, therefore, can provide implication for catalysis in gen-
eral as well as efficient targeting of Cyclophilin A in pathogenic settings. In addition, we were also inter-
ested in exploring the entropic effects of substrate confinement by enzyme and its implication for bind-
ing energy. Our results suggest that the loss in conformational entropy at the transition state relative to 
the cis and trans states in the free substrate is decreased in the complex. This relative change in confor-
mational entropy contributes favorable to the free energy of stabilizing the transition state by CypA.  
In another part of this work, the effects of intramolecular polarization, as a result of the loss of 
pseudo double bond character of the peptide bond at the transition state, were investigated. The results 
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showed that intramolecular polarization contributes only about −1.0 kcal/mol to stabilizing the transi-
tion state. This relatively small contribution demonstrates that routinely used fixed charge classical force 
fields can reasonably describe these types of biological systems. The results from this work provide fur-
ther insights into the mechanism of CypA, a member of a poorly understood family of enzymes that are 
central to many biological processes. 
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2 MOLECULAR DYNAMICS SIMULATION  
2.1 Abstract 
A broad range of experimental techniques is now being applied to extract information on 
biomoleculars structure, dynamics and function. However, the extent of spatial and temporal resolution 
imposed by experimental methodologies limits the accessible level of precision and accuracy in such 
methods. On the other hand, computational modeling has been proven as a promising tool in response 
to demands for more precise and predictable description of biological structures, dynamic behavior, and 
function. Among the computational methods, Molecular Dynamics (MD) is now widely applied in differ-
ent areas of biomolecular simulations such as computer-aided drug discovery and free-energy predic-
tion. Although the computational expenses and sampling issues have been a major concern in the appli-
cation of MD simulations, there has been substantial progress toward addressing these limitations, mak-
ing MD as a more reliable method in biomolecular modeling. In this chapter, a summary of MD simula-
tion method, its applications, and limitations are presented. Finally, a summary of recent advances in 
MD methodology with an emphasis on Accelerated Molecular Dynamics (the enhanced-sampling meth-
od used in the present work) is presented.  
2.2 Introduction 
 The study of function and highly dynamic nature of biomolecules entails using analysis tech-
niques that go beyond the static picture determined by crystallography or other experimental meth-
ods(1). Molecular Dynamics is one of the promising methods that provide the temporal and spatial evo-
lution of systems based on Newtonian physics. By using a force field (a combination of physics laws and 
parameter derived from QM or experimental data), the forces acting on each atom are computed. The 
positions and velocities of particles at each time step are then updated as system evolves. The desired 
information (e.g. interactions, radial distribution function, autocorrelation function, etc.) are then 
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extracted from the data of temporal and special evolution of the system. The timescale of MD depends 
on the size and nature of the system or process under study. 
2.3 Applications 
MD is now used in a wide range of studies on biomolecular system to elucidate information 
related to interaction energy, protein folding, channel gating and other important biological event 
involving protein, nucleic acids, carbohydrates and lipid bilayers. A summary of some examples of appli-
cation of MD in study of biomolecular systems is presented below. 
2.3.1 Protein Folding and unfolding 
One application of MD in studying protein folding is illustrated in the study on several unfolded 
conformations of a variant of HP-35 NleNle molecule with simulation time scale comparable to the ex-
perimental folding time(2). With no need to assume a conventional two-state kinetic or a Markov state 
model, the relaxation to the folded state was monitored for retrieving experimental observable 
(quenching of tryptophan by histidine). The MD simulation showed that the relaxation rate to the folded 
state and the number of resolvable kinetic time scales depend upon starting structure(2). In addition, 
those starting structures with folding rates most similar to experiment are suggestive of the existence of 
some native-like structural elements in the experimentally relevant unfolded state. This  large-scale MD 
simulation, therefore, reveal kinetic complexity that is not resolved in the experimental data(2).  
Another example of the complimentary role of experimental and computational studies is 
highlighted in the work of Ladurnel et al. (3). Using the experimental data from protein engineering and 
NMR spectroscopy, this work developed algorithms for helix propensity, folding pathways and energy 
landscapes. The MD simulations of the unfolding of chymotrypsin inhibitor 2 (CI2) showed the transition 
state ensemble for unfolding/folding of the protein. These simulated transition state structures were 
then used to design faster folding mutants of CI2. The models also detected some unfavorable local in-
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teractions that, when removed, the rate of folding of the protein was increased up to 40-fold(3). This 
study again highlights the significant progress toward describing complete folding pathways at atomic 
resolution by using a combination of experiment and simulation(3). 
2.3.2 Transport System 
MD simulation can be also applied to monitor the motions of each atom during conformational 
changes necessary for transport of different molecules across the membrane. In this regards, MD simu-
lations have been used for the study of different biological transport systems including aquaporins, ion 
channels, and active transporters(1). These studies have provided important information on the mem-
brane transportation including the mechanism of the fast rate of substrate permeation in channels, sub-
strate selectivity and transport regulation  in response to various stimuli(1). 
Arkin et al.(4) used MD simulation for Na+/H+ antiporters that their timely function is central to 
cellular salt and pH homeostasis. Using  existing experimental data the study identified three conserved 
aspartates that are key to an atomically detailed model of antiporter function (4). These residues control 
the pH and binding site as well as alternating accessibility of binding site to the cytoplasm or periplasm. 
The simulation also detected two protons that are required to transport a single Na+ ion; A protonated 
D163, which revealed the Na+-binding site to the periplasm, and the subsequent protonation of D164 
that releases Na+(4).  
In another study by Jensen et al.(5), the permeation of hundreds of ions through a potassium 
channel was followed by applying microsecond-timescale MD simulations at different transmembrane 
voltages (1, 5). The study identified transitions between microscopic states that cause the permeation of 
an individual ion(1). A “knock-on” conduction mechanism, by which the translocation of two selectivity-
filter-bound ions is triggered by a third, incoming ion, was therefore presented with atomic details by 
MD simulation (1, 5).  
 
24 
2.3.3 Molecular Interactions 
New developments in MD methodology have also allowed atomic-level monitoring of protein in-
teraction in intra and extracellular environment in a wide range of pathways. For instance, one study by 
Buch et al.(6) highlights the power of MD in complete reconstruction of the enzyme-inhibitor binding 
process for trypsin-benzamidine complex.  In this study, through running a total number of 495 MD sim-
ulations of the binding process, 187 binding events were detected from which the binding paths were 
constructed. The paths can predict the kinetic pathway of the inhibitor diffusing from solvent to the 
bound state and passing through two metastable intermediate states instead of directly entering the 
binding pocket. In addition, the simulation gives a standard free energy of binding comparable to the 
experimental value and a two-states kinetic model with related rate constants for unbound to bound 
transitions(6).  
MD simulation has been also used in the discovery of potent Anti-HIV agents that target the 
Tyr181Cys variant of HIV Reverse Transcriptase(7). Previous studied have developed two non-nucleoside 
reverse transcriptase inhibitors (NNRTIs) that inhibit HIV replication. Although these compounds inhibit 
replication of wild-type HIV-1 in infected human T-cells with different EC50 values, they show no activity 
against viral strains containing the Tyr181Cys (Y181C) mutation(7). Modeling the binding process de-
tected the underlying problem as an extensive interaction between the dimethylallyloxy substituent and 
Tyr181. Although this undesirable contact can be diminished by substitution with a phenoxy group, but 
it also lead to a loss of inhibition activity of about 1000-fold(7). This problem was then solved by using 
FEP (free-energy perturbation) substituent scans to find the benefits of addition of a cyanovinyl group to 
the phenoxy ring. The study exemplified the efficient construction of novel NNRTIs with high potency for 
both wild-type HIV-1 and Y181C-containing variants using MD simulation(7).  
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2.3.4 Computational Protein Design  
MD techniques have also been widely used in computational protein design where the structure 
or enzymatic activity are optimized for various application such as  biosensors, industrial catalysts, or 
therapeutic antibodies(1). For instance Sun et al., worked on Graphene and its water-soluble derivative, 
graphene oxide (GO) which show interesting physical and chemical properties with wide applications in 
biotechnology and biomedicine(8). GO has been shown to be the most efficient inhibitor for α-
chymotrypsin (ChT) but the nature of its interaction with bioactive proteins and its potential in enzyme 
engineering are not well understood(8). Using MD simulation, the authors investigated the interactions 
between ChT and graphene/GO and found that ChT is adsorbed onto the surface of GO or grapheme 
through one α-helix as an important anchor to interact with GO. The strong cationic and hydrophobic 
interaction between ChT and GO leads to the deformation of the enzyme active site and its inhibition. 
The adsorption of ChT onto the graphene surface has little effect on its active site. In addition, its sec-
ondary structure is not affected after being adsorbed onto GO or graphene surface. This study highlights 
another example of MD technique as a tool for designing efficient artificial inhibitors(8). 
2.3.5 MD Simulation of Nucleic Acids 
Contrary to the common picture of nucleic acids as static structures, experimental investigations 
of both RNAs and DNAs have revealed their diverse structure, function, and dynamics(1). Nevertheless, 
due the smaller number of available nucleic acid structures and imperfect force fields the number of MD 
simulations of nucleic acids are far less than those of proteins(9). One main consideration in simulation 
of nucleic acid is the treatment of high charge density of nucleic acids and commonly associated divalent 
cations(1). This molecular feature of nucleic acids implies that the simple point charges model may not 
work well in these systems and therefore considering polarization effects may be essential(1). 
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2.4 Limitations of MD simulations 
The timescale accessibility of MD methods has long been the main challenge for different bio-
molecular simulation. The timescales accessible to MD is shorter than that of most biomolecular events 
of interest and, therefore, would result in limited applicability of MD simulations(1). Until recently MD 
simulations were limited to nanosecond timescales with very high computational cost for simulations of 
even a few microseconds(1). While recent advances have increased the timescales accessible to simula-
tion up to millisecond-scale, these techniques are still computationally expensive and not applicable for 
all biochemical processes. 
The accuracy level of the force field models is another challenge for a reliable MD simulation. 
The force fields used in the simulation are based on quantum-mechanical approximations and experi-
mentally derived parameters. In addition, classical MD simulations are limited to chemical processes 
with no or little quantum effects such as bond formation and cleavage or polarizability. These limitations 
are now addressed by using polarizable force fields or applying hybrid MD/QM methods where quantum 
effects are captured in particular part(s) of system while other areas are treated by MD simulation(10). 
2.5 Advanced Techniques in MD Simulation: Accelerated MD 
Although the basic form of MD simulation has been unchanged over decades, the speed and ac-
curacy of these simulations have improved substantially over the past few years(1). A wide range of   
developments in hardware, software, and methodology aims to maximize MD capabilities to access 
longer timescales as well as to improve force field accuracy. These methods include the parallelization 
across general-purpose computer chips(1, 11),  developing graphics processing units(12), and special-
purpose parallel architectures( such as Anton)(1, 13).  
In addition, the long-timescale simulations demands different level of accuracy in force fields; a 
force field that is sufficient for short-timescale simulations may not work well at longer timescales and, 
therefore, may need parameter readjustments(1). These adjustments have been carried out for torsion-
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al angles in protein backbone and side chain, charge distributions of ionizable amino acid residues as 
well as different parameters for lipids and small drug-like molecules(1). 
On the other end of a wide range spectrum of techniques aimed to make Molecular Dynamics 
simulation even more efficient are enhanced sampling methods. These methods have been increasingly 
used in the simulation of events not accessible by conventional MD. Examples of these techniques in-
clude targeted molecular dynamics(TMD)(14), Replica Exchange Molecular Dynamics(REMD)(15), um-
brella sampling(16), metadynamics(17) and accelerated molecular dynamics (aMD)(18). While the tech-
niques based on simple potential modifications such as  TMD have provided valuable conformational  
information, the REMD methods have proven to  enhance sampling of the energy landscape(19). How-
ever,  because of the alteration in the actual kinetics of the systems under study the success of these 
methods has been empirical rather than rigorous(19). In addition, most of the enhanced-sampling 
methods need a priori knowledge about the energy landscape of the system. Nevertheless, successful 
application of enhanced sampling methods can be achieved by considering its specific contexts(19).  
Accelerated MD (aMD), the method used in our work, is the enhanced-sampling method with no 
need for a prior knowledge of the energy landscape of the system. The accelerated MD has been shown 
to accurately and efficiently explores conformational space with improved sampling(18). The application 
of aMD simulation in our study provided insightful information on the atomic details of uncatalyzed and 
CypA-catalyzed peptidyl-prolyl isomerization. The aMD method was proposed by Hamelberg et al.(18), 
based on the earlier hyperdynamic model(20) which simulates infrequent biomolecular events without 
any prior knowledge of the energy landscape. In the hyperdynamic method the potential energy surface 
V(r), is modified by adding a bias potential, ∆V(r), to create an altered potential, V*(r), such that the 
potential surfaces near the minima are raised and those near the barriers are left unaffected(18)(Figure 
2).  
V*(r) = ∆V(r) + V (r)    (2-1) 
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Figure 2 Accelerated molecular dynamics method as represented by normal potential, the biased poten-
tial, and the threshold boost energy, E. 
 
Previous suggestions for defining ∆V(r) suffer from different problems such as high computa-
tional cost, discontinuity in calculations, low accuracy and the changes in the shape of energy 
surface(18). The aMD method, however, suggested a new ∆V(r) in a way that maintain the underlying 
shape of the unmodified potential energy surface. In addition, the problem of discontinuity in calcula-
tions is removed by smoothly merging the modified potential with the original potential at a threshold 
‘‘boost energy’’ value of E(18). The ∆V is therefore defined as: 
 
 ߂ܸ(ݎ) = 	 ൫ாି௏(௥)൯ଶ
ఈା(ாି௏(௥))         (2-2) 
 
Where α is a tuning parameter, that determines how deep the modified potential energy basin 
would be(18).  
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Selection of E and α determines how the potential of the system will be altered and how aggres-
sively the molecular dynamics will be accelerated. The appropriate choices of E and α are important for 
efficient and accurate sampling of the energy landscape. In general, E should be greater than the mini-
mum of V(r) near the starting structure. Otherwise, the simulation will always be performed on the true 
potential that is simply a normal MD simulation. For large molecules with multiple minima very close 
together, an average potential energy on the true potential can be used as Vmin.  Since at low values of E 
the modified potential falls below most of the transition state regions with the same probability of 
escape as unmodified potentials, the choice of α is not that critical to the overall potential energy 
landscape. However, at high value of E, the modified potential becomes isoenergetic in most places for 
small α, and the molecular system experiences a random walk. Therefore, in order to maintain the basic 
shape of the potential energy surface at high values of E, and preserve the same potential energy wells 
that is present on the unmodified potential surface, α has to be set to a much higher value than zero.  
The statistics sampled on the biased potential are then corrected to remove the effect of the 
leading to convergence to the correct canonical probability distribution(18). Normally, the sampled 
points of a system from an altered Hamiltonian are reused with different statistical weights to evaluate 
its properties at the original potential(21). A statistical analysis of the precision of reweighting-based 
simulations such as accelerated MD provided a quantitative method to estimate the number of sampled 
points required in the crucial step of reweighting of these methods(21). These information and analysis 
can provide a priori guidance for the strategy of setting up the parameters of advanced simulations be-
fore a lengthy one is carried out.  
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3 Enzyme-Substrate Interactions 
3.1 Abstract 
The precise catalytic mechanism of peptidyl–prolyl cis–trans isomerases (PPIases) has been elu-
sive, despite many experimental and computational studies. Here, we investigated the interactions be-
tween cyclophilin A and a well-studied substrate analogue through exploring the conformational space 
using accelerated molecular dynamics, free in solution and in the active site of CypA. The enthalpic and 
entropic contributions in isomerization were probed via conformational interconversion during catalysis. 
We show that the undemanding exchange of the free substrate between β- and α-helical regions is lost 
in the active site of the enzyme, where it is mainly in the β-region. Our results suggest that the loss in 
conformational entropy at the transition state relative to the cis and trans states in the free substrate is 
decreased in the complex. This relative change in conformational entropy contributes favorable to the 
free energy of stabilizing the transition state by CypA. We also show that the ensuing intramolecular 
polarization, as a result of the loss of pseudo double bond character of the peptide bond at the 
transition state, contributes only about −1.0 kcal/mol to stabilizing the transition state. This relatively 
small contribution demonstrates that routinely used fixed charge classical force fields can reasonably 
describe these types of biological systems. Our results provide further insights into the mechanism of 
CypA, a member of a poorly understood family of enzymes that are central to many biological processes 
3.2 Introduction 
In the kinetic sense, enzymes can facilitate a chemical reaction by effectively reducing the free 
energy barrier separating the reactants and products. The free energy barrier of isomerization in CypA-
substrate bound complex includes enthalpic and entropic components that originate from favorable (or 
unfavorable) intramolecular interactions, as well as desolvation of the substrate as it binds to the active 
site of the enzyme. 
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Previously (1, 2), accelerated molecular dynamics was used to investigate the catalytic 
mechanism of cyclophilin A. The cis–trans isomerization of a substrate analogue with a −Gly–Pro– motif 
derived from the HIV-1 capsid monomer was simulated directly, without any conformational constraint, 
free in explicit water and in the active site of cyclophilin A. The resulting reweighted free energy profiles 
suggested that catalysis occurs mainly through the stabilization of the transition state in the active site 
due to a combination of favorable hydrophobic and hydrogen bonding interactions (Figure 3). However, 
in addition to these specific interactions that are mainly enthalpic in nature, little is known about possi-
ble entropic effects on the free energy of stabilizing the transition state. In trying to fully understand the 
mechanism of CypA, we have further examined the conformational phase space of the well-studied 
substrate analogue, Ace–Ala–Ala–Pro–Phe–Nme, with improved dihedral force field parameters(3) for 
the ω-bond angle, free in solution and in the active site of CypA. The conformational preferences of the 
substrate have entropic implications for the free energy of stabilizing the transition state since the rela-
tive change in the conformational entropy of binding would affect the binding free energy. 
 
Figure 3. Cis–trans isomerization of the peptidyl–prolyl bond of a substrate analogue with the −Ala–Pro– 
motif by CypA. (Left) The binding site of CypA with the hydrophobic pocket and some of the key residues 
highlighted. (Right) The relatively planar configurations of the cis and trans isomers separated by a py-
ramidal transition state in the active site of CypA. 
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In the second part of this chapter, the issue of conformational dependence of partial atomic 
charge and its effect on electrostatic interaction and binding energy are discussed. As indicated in stud-
ies by Warshel and co-workers (4, 5), the catalytic effect is primarily due to electrostatic effects that 
provide important enthalpic contributions to enzyme catalysis. These contributions originate from a bet-
ter stabilization of possible charge buildup at the transition state in the active site than in water (5). 
Therefore, the importance of electrostatics contribution in enzyme catalysis calls for precise treatments 
of the electron distribution, which is modeled as partial charges. The electron distribution and resulted 
electrostatic and binding energy are subjected to the effects of polarizability during catalysis. The 
polarization effects (electron redistribution) arise not only from the environment (solvent or enzyme 
active site) but can also be originated from the geometrical variations in the molecular structure of the 
substrate itself(6-9). The Intramolecular polarization is referred to redistribution of the electron cloud in 
response to alteration of the internal electric field arising from changes in nuclei positions in the mole-
cule. Different methods have been developed to incorporate both inter- and intramolecular polarization 
effects in polarizable force fields (10-13). However, pure classical molecular dynamics simulations would 
not accurately capture intramolecular polarization resulting from geometrical change in processes such 
as peptidyl–prolyl cis–trans isomerization. This limitation implies the possibility of considerable error  
associated with the calculation of electrostatic, conformational and binding energies of a compound(14). 
During isomerization of the peptidyl–prolyl bond (Figure 3), the transition state partially loses the pseu-
do double bond character of the ω-bond angle that leads to redistribution of the electrons, especially on 
the nitrogen. What is the effect of charge redistribution at the transition state on the substrate binding 
energy and catalytic mechanism of CypA? The answer to this question is important for two reasons: one, 
it will allow us to understand the suitability of the fixed charge model for studying the catalytic 
mechanism of cyclophilin A, and two, it will provide the free energy contribution of the charge 
redistribution to the stabilization of the transition state by CypA. Therefore, in this work, we have de-
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termined the effect of intramolecular polarizability (redistribution of the partial charges at the transition 
state) on the binding free energy of the substrate in the transition state by CypA. 
3.3      Computational Method 
3.3.1      The MD Simulations of Catalytic Process of cis–trans Isomerization 
The simulations were carried out with the well-studied substrate analogue, Ace–Ala–Ala–Pro–
Phe–Nme, and the 1.58 Å resolution crystal structure complex of CypA with PDB ID 1AWR. The substrate 
analogue in the complex was modified from HAGPIA to Ace–AAPF–Nme. The coordinates of the back-
bone atoms and the common atoms of the side chain residues were kept the same. The xleap module in 
AMBER was used to add the missing atoms and solvate the free peptide and enzyme-bound substrates 
with explicit TIP3P water model(15) in a cubic and octahedron box, respectively. All simulations were 
run using the AMBER 10 suite of programs(16) with the modified version(17) of the parm99(ff99SB) all-
atom force field(18) and the reoptimized dihedral parameters for peptide ω-bond(3). The systems were 
equilibrated in the NTP ensemble with pressure of 1 bar and temperature of 300 K followed by MD 
simulations. During all simulations, the temperature was regulated with a Langevin thermostat with a 
collision frequency of 1 ps–1. A cutoff of 10.0 Å was applied for nonbonded short-range interactions 
while the long-range electrostatic interactions were treated by the particle mesh Ewald method(19). All 
bonds involving hydrogen atoms were maintained using the SHAKE algorithm(20). A time step of 2 fs 
was used to numerically integrate Newton's equation of motions. 
The simulations were carried out with accelerated molecular dynamics (1, 21), in order to accel-
erate the rate of the slow cis–trans isomerization of the peptidyl–prolyl bond. A modified version of 
pmemd in AMBER 10 suite of programs was used to run all accelerated molecular dynamics simulations. 
For the free substrate in water, five independent accelerated MD simulations were carried out for a 
total time of 1.3 μs using a boost energy E of 60 kcal/mol above the average total dihedral energy 
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calculated after equilibration and α of 10 kcal/mol. For the CypA complex in water, we carried out eight 
independent accelerated MD simulations (a total time of 1.19 μs) with the ligand selectively boosted, (2, 
22) using the same boost parameters as the free substrate. The configurations were then reweighted by 
the strength of the Boltzmann factor of the bias potential energy, exp[βΔV(r)], in order to calculate the 
probability distributions. The Boltzmann reweighting is exact, and the related statistical analysis on the 
precision has been previously discussed(23). 
3.3.2      Calculating Atomic Partial Charges at the Transition State 
We created the initial configuration of the Ace–Ala–Pro–Nme, with the peptidyl–prolyl bond of 
Ala–Pro in the transition state, i.e., ω ≈ 90°, using the xleap module in AMBER. The transition state con-
figuration of the Ace–Ala–Pro–Nme was then minimized using the Gaussian03 program(24), and the 
electrostatic potential was calculated at the HF/6-31G* level of theory. The calculated electrostatic po-
tential was then used to obtain partial charges using the standard two-step RESP method (25, 26). The 
partial charges of Ace and Nme were set to those in the standard AMBER force field. We therefore only 
allowed the partial charges of the central −Ala–Pro– motif to vary in the transition state of the substrate 
analogue, Ace–Ala–Ala–Pro–Phe–Nme. 
3.3.3      Free Energy Calculations 
Thermodynamic integration(27) was used to calculate the relative binding free energy of the 
substrate in the transition state by CypA between the two states: the initial state has the standard 
partial charges from the AMBER force field and the final state has the recomputed partial charges 
specific to the transition state configuration. In this regard, free energy is defined as a function of a 
developing, coupling parameter, λ, which represents the progress of the partial charges of the transition 
state from an initial state (with AMBER standard charges) to the final state (with redistributed charges). 
The configuration of the peptidyl–prolyl bond of the Ala–Pro motif of the substrate was maintained at 
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the transition state by restraining the ω-bond angle around 90° using a flat-bottomed well potential with 
a force constant of 1000 kcal/mol/rad2. A seven-point Gaussian quadrature was used, with λ values cor-
responding to 0.02544, 0.12923, 0.29707, 0.50000, 0.70292, 0.87076, and 0.97455, to approximate the 
integral of the total free energy. Three separate runs with different initial random seeds were carried 
out for each window. 
3.4      Result and Discussion 
3.4.1      Free energy landscape of the catalyzed and uncatalyzed processes 
Free energy profiles provide interesting information about the extent of interactions between 
enzyme and substrate during isomerization. To obtain free energy profiles, extensive aMD simulations of 
around 1.2 μs for each free and CypA-bound substrate (Ace-Ala-Ala-Pro-Phe-Nme) were carried out(28).  
The free energy profiles show distinctive features of isomerization in free and enzyme-bound substrate 
(Figure 4A). Most noticeable is the directionality of isomerization (from trans to cis or vice versa in the 
active site of the enzyme) as compared to symmetrical isomerization in free substrate. Also, binding 
energy of the transition state has a lower free energy than that of cis and trans isomers, resulting in a 
net reduction of free energy barrier by approximately 9 kcal/mol from trans to cis. Even when effects of 
the kinetic prefactor of a typical kinetic rate equation are ignored, this reduction in barrier height alone 
can account for more than 5 order of magnitude of speedup in the rate of isomerization in the presence 
of CypA.  How does cyclophilin make such a big difference in the rate of peptidyl-prolyl isomerization? 
The interactions between the enzyme and the substrate are sensitive to the configuration of the sub-
strate (2, 28, 29). The substrate in the transition state configuration makes the most favorable hydrogen 
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Figure 4.  (A) The free energy profiles along the ω-bond angle of the –Ala–Pro– motif, for the free 
substrate (black) in solution and in the enzyme–substrate complex (red). (B) Thermodynamic cycle con-
necting the free energy of the substrate (S) binding to CypA and free energy of cis–trans isomerisation 
with t, ts and c represent the trans, transition state, and cis configurations, respectively. The barrier 
heights are obtained from the free energy profiles in (A). CypA+Sx, where x is c, ts or t, means both CypA 
and Sx are free in solution and CypA:Sx means the enzyme–substrate bound complex. 
 
bonding interactions (mainly between the substrate and Arg55, Asn102, Gln63 and Trp121 of CypA; 
Figure 5A) in addition to the hydrophobic effects involving the substrate proline and the proline-binding 
pocket of CypA(2, 29). It was shown that although these interactions can be formed when the substrate 
is in the cis and trans configurations, they are best formed in the transition state (Figure 5B), resulting in 
more favorable free energy of binding the transition state relative to the other states. The more favora-
ble interactions with the transition state configuration result in a lower free energy barrier as compared 
to the uncatalyzed isomerization. Upon binding the cis or trans state of the substrate, the free energy of 
the complex has to be lower than the sum of the free energy of the free substrate and free CypA. The 
barrier separating the cis and trans configuration in the catalyzed reaction therefore can only be lower 
than that of the uncatalyzed reaction, only if the difference in magnitude between the free energy of 
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the CypA-transition state complex and the sum of free CypA and free substrate in transition state is 
greater than that when the substrate is in the cis or trans state (Figure 4B). In effect, the free energy of 
interaction between the enzyme and substrate in the transition state has to be much more favorable 
than that between the substrate in the ground states and the enzyme, in order to have a lower free 
energy barrier during catalysis. 
 
 
Figure 5.  (A) Key active site residues (Arg 55, Gln 63 and Asn 102) and Trp 121 that form hydrogen 
bonds with the substrate, and the substrate in the transition state configuration (yellow). The probabil-
ity distributions of hydrogen bond distances between CypA and the substrate in the (B) trans, (C) transi-
tion-state and (D) cis configurations. Hydrogen bonds are formed between Arg 55 guanidinium carbon 
and the carbonyl oxygen of the substrate Pro (magenta), the backbone nitrogen of Asn 102 and the 
carbonyl oxygen of Ala (royal blue), the backbone oxygen of Asn 102 and nitrogen of Ala of (cyan) and, 
the side-chain amino nitrogen of Gln 63 and the carbonyl oxygen of Ala, preceding the –Ala–Pro– motif 
(orange) (from Ref.29 ). 
 
The directionally of the isomerization process has also been a source of contention. The free 
substrate can isomerize in either direction from cis to trans and vice versa. NMR studies suggested that 
the C-terminus rotates during catalysis(30). However, analysis using solved X-ray crystal structures sug-
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gested that the N-terminus, not the C-terminus, rotates during catalysis(31). Our simulations clearly 
showed that it is the N-terminus that rotates during catalysis in the clockwise direction (toward +90 °), if 
one is looking down the C-N bond, through the positive direction (Figure 5A). The origin of the 
directionality of isomerization during catalysis is explained by the favorable hydrogen-bonding 
interaction between the carbonyl oxygen of the peptidyl-prolyl bond angle and the backbone hydrogen 
of Asn 102 of CypA (2), rendering the path more favorable than the opposite rotation. Rotation of the C-
terminus is highly unfavorable since the side-chain of the proline residue of the substrate is snuggled in 
the hydrophobic cavity of the active site of CypA in all of the different states of the substrate.   
3.4.2      Conformational Confinement by the Enzyme and Entropic Implications  
It is established that CypA binds the substrate in the transition state configuration more favorably than 
the cis and trans states.(2, 28, 32, 33) The free energy of binding is due to an enthalpic contribution, 
which is a result of the enzyme-substrate interactions, and entropic contributions, which can be 
attributed to loss or gain in conformational flexibility during catalysis. The entropic contributions to the 
free energy barrier may originate from the solvent,(34) substrate,(35) and the enzyme.(36) We focus on 
the possible entropic contributions to the lowering of the catalytic barrier due to conformational 
changes of only the substrate, assuming that the relative change of the others is small for the different 
states of the substrate.  
The conformational phase space of the -Ala-Pro- motif of the substrate analogue in the free substrate 
and CypA-substrate bound complex are shown in Figure 6. These conformational changes of the 
substrate as projected on the φ-ψ backbone of proline (Figure 6A) show that, despite an apparent 
preference for the β-region over the α-helical region for the free substrate, the energetic barriers 
between α- and β-regions is low enough to allow for undemanding interconversion between these 
conformational sub-states. On the other hand, the enzyme limits the flexibility of the substrate and con-
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fines it to the predominantly β- and polyproline II (PPII)-regions. Similar behavior with minor changes 
was observed when the phase space is projected on the φ-ψ of the preceding Ala residue.  
 
 
Figure 6.Two-dimensional contour plots in kcal/mol of the conformational space of Pro in the (A) free 
substrate and (B) enzyme–substrate complex. Shown are the φ – ψ or Ramachandran plot (top) and the 
Ψ–ω dependency (bottom) of the –Ala–Pro– motif 
 
A previous study (37) of the catalytic mechanism of CypA using metadynamics showed that the 
free substrate with a −Gly–Pro– motif preferred being in the α-helical region to the β-region, contrary to 
our present results. We believe that this discrepancy is not due to differences in the sequence but due 
to the choice of the force field since the present results are similar to earlier studies of cis–trans 
isomerization in different sequences(38). The older AMBER parm99 force field used in their study is 
known to overstabilize the α-helical conformation of protein backbone and has since been modified to 
parm99SB in order to correct this problem. We are using the updated parm99SB force field, with correc-
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tions for the dihedral parameters of the ω-bond angle(3). However, despite over stabilization of the α-
helical region of the free substrate in their study, the β-sheet and PPII conformations of the substrate 
were found to be more stable in the complex, inline with our present findings, emphasizing the 
preference for the backbone of the substrate in the β and PPII conformations by CypA 
The restriction of the substrate in the β/PPII-region upon binding to the enzyme is also 
represented by the 2D free energy projection on the peptidyl-prolyl ω-bond and the ψ of proline as 
shown in Figure 6B. This conformational confinement brings about important entropic implications for 
catalysis. The evolution of the conformational state of the substrate from either trans or cis basin to the 
low-accessible transition state involves inherent negative conformational entropy changes. The loss in 
entropy due to reaching transition state in the enzyme is less than that of the free substrate, which has 
more open conformational space to explore. 
Considering the free energy of binding. the cis or trans (ΔGcis/trans) and transition states (ΔGts), 
then ΔGcis/trans = ΔHcis/trans – TΔScis/trans  and ΔGts = ΔHts – TΔSts. The relative free energy of binding the tran-
sition state, ΔΔG = ΔGts – ΔGcis/trans = ΔΔH – TΔΔS. Therefore, a positive ΔΔS change in the conformational 
entropy will result in a more negative ΔΔG, leading to a lower free energy barrier of isomerization in the 
active site of the enzyme. The lowering of the free energy is therefore mainly due to the enthalpy (hy-
drophobic and hydrogen bonding interactions), but is also entropically (confinement of the substrate in 
the active site) driven.  
3.4.3      Surprisingly Small Intramolecular Polarization Effect 
Accurate treatment of electrostatic interactions in classical molecular dynamics simulations 
relies, in addition to other force field parameters, on precise calculation of atomic partial charges and 
accounting for possible polarization effects.(39) In general, it is assumed that the fixed partial charges 
are transferable from one conformation to the other in typical classical molecular mechanics force 
fields. However, alteration of the environment and the conformation can easily polarize the atoms (8, 
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40-42). The conformational dependence of atomic partial charges has therefore long been considered 
for accurate treatment of intra- and intermolecular energies. For example, a quantum mechanically 
calculation of the difference in the free energy of hydration between ethanol and propanol reveals that 
the main errors are due to neglecting the variations in the atomic partial charges during conformational 
changes(14).  
During cis–trans isomerization of peptidyl-prolyl ω-bond, the relatively planar geometry in the 
cis and trans ground states becomes pyramidal in the transition state (Figure 7).(3, 43) The nitrogen 
atom of proline in the amide bond is pushed out of plane, which would naturally lead to the localization 
of the electron and loss of the pseudo double C–N bond character. This electronic rearrangement would 
lead to a new distribution of partial charges, especially on atoms around the peptidyl-prolyl ω-bond (in-
tramolecular polarizability). The maximum partial charge redistribution is expected at the transition 
state because it has the highest degree of the conformational distortion from the planar cis and trans 
ground states. How much does this redistribution of atomic charges affect the electrostatic energy and, 
therefore, the free energy of binding the transition states by CypA? As shown earlier (Figure 4), a pure 
classical description of the system with a fixed charge model (without accounting for charge 
redistribution in the transition state) shows a reduction of approximately 9 kcal/mol in the free energy 
barrier of CypA-catalyzed isomerization. However, does the system utilize the change in electronic struc-
ture for further stabilization of the transition state and barrier crossing?  
To answer this question, we carried out free energy calculations using thermodynamics 
integration to estimate the relative change in free energy of binding the transition state by CypA with 
two different sets of partial charges: the normal fixed AMBER partial charges that correspond to the 
substrate in the trans state and that of the redistributed partial charges recomputed using the transition 
state configuration. As mentioned earlier, the transition state binds to the enzyme better than the cis 
and trans isomers with the maximum conformational distortion from the ground states. 
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Figure 7. Pyramidalization on both sides of a proline nitrogen during Isomerization. Right: Typical pyram-
idal conformations in transition state. Left: The free energy landscape of the Ace−Pro−NMe as a funcƟon 
of the pyramidality and the reaction coordinate ω′ (from Ref 43) 
 
Quantum mechanical calculations were carried out on the Ace–Ala–Pro–Nme motif (Figure 8A) 
to compute the electrostatic potential at the HF/6-31G* level of theory, fixing the configuration of the 
prolyl–peptide bond at the transition state. The RESP method (25, 26) was then used to calculate the 
partial charges on atoms in the Ala–Pro motif at the transition state (Figure 8B). According to the 
thermodynamic cycle shown in Figure 8C, the binding free energies corresponding to the two sets of 
charges (ΔG2 and ΔG4) are connected to the changes in free energies when the substrate undergoes 
charge redistribution free in solution and in the active site of CypA (ΔG3 and ΔG1, respectively). There-
fore, the relative binding free energy of the substrate in the transition state with the redistributed par-
tial charges, as compared to the regular AMBER partial charges, is ΔΔG = ΔG2 – ΔG4 = ΔG1 – ΔG3. This rel-
ative free energy difference (ΔΔG) was calculated to be −0.6 ± 1.2 kcal/mol. The diﬀerence is small and, 
at first,        surprising.  
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Figure 8. A) Motif of −Ala–Pro– of the substrate analogue in the transition state with the atoms defined. 
(B) Partial atomic charges of the −Ala–Pro– motif as defined in the AMBER force field (ts) and the 
recomputed partial charges in the transition state configuration (ts*). (C) Thermodynamic cycle connect-
ing the free energy of binding and free energy of charge redistribution of the substrate free in solution 
and in the active site of CypA–substrate complex. P and S represent the enzyme and substrate, respec-
tively; ts and ts* represent the transition state with the AMBER force field partial charges and the 
recomputed partial charge for the transition state configuration, respectively. 
 
The surprisingly small effects of intra-polarizability can, however, be explained by the binding in-
teractions. As described earlier, isomerization is facilitated in the active site of the enzyme mainly 
through a combination of favorable hydrophobic and long-lasting hydrogen bonding interactions. The 
two well-formed H-bonds are between the carbonyl oxygen of the peptidyl prolyl bond and the 
backbone NH group of Asn102, as well as between the guanidinium moiety of Arg55 and the carbonyl 
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oxygen of proline (Figure 3A). The partial charges of the atoms directly involved in these interactions 
change only slightly, while the overall net charge during isomerization is constant. The nitrogen atom of 
proline, with the maximal increase in the magnitude of the partial negative charge, has little 
contribution to hydrogen bonding due to its average distance of about 4 Å from the nitrogen atom of 
the guanidinium moiety of Arg 55. We could, therefore, conclude that for these types of systems, the 
use of the fixed charges is sufficient to capture the majority of the electrostatic interactions during ca-
talysis. 
In addition to studying the effects of charge redistribution on the relative free energy of binding 
the transition state, we also took into account changes in several bond lengths, especially the C–N 
peptide bond during the free energy calculations. Conformational dependence of bond lengths(44) is 
not as influential on the free energy as that of dihedral angles, but the evidence of such effects have 
been previously studied(45). Here, we looked for possible effects of such bond length changes on the 
relative binding free energy of the transition state by CypA. The bonds that are around and directly in-
volved in the peptidyl–prolyl amide ω-bond were allowed to change during the free energy calculations, 
in addition to the partial charges. Comparison of QM optimized bond lengths at the transition state and 
those obtained from the AMBER force field parameters shows only small differences. As expected, the 
bond lengths that changed the most include the C–N (peptide), as well as the C═O, N–Cα, and N–Cδ 
bonds. The changes observed for C–N and C═O bonds are especially in accordance with expected 
changes in bond lengths due to the loss of the pseudo double bond character of the peptide bond in the 
transition state. The electronic rearrangement in the transition state led to an increase in the C–N bond 
length from 1.33 to 1.41 Å, similar to previous observation(43), and a small decrease (about 0.04 Å) in 
the bond length for the C═O bond. Therefore, the variation of bond lengths and the partial charges dur-
ing isomerization did not make any noticeable difference in the calculated relative binding free energy.  
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3.5      Summary 
Molecular dynamics simulations were used to investigate the uncatalyzed and catalyzed cis–
trans interconversion and the role of intramolecular polarizability of the substrate in the catalytic mech-
anism of CypA. As previously observed, preferential binding of the transition state of the substrate by 
CypA is the dominant contribution to catalysis. We show that the conformational space of the substrate 
is more restricted in the active site of the enzyme than when it is free in solution. The results suggest 
that the relative change in conformational entropy of binding the transition state by CypA is positive, 
contributing favorably to the relative free energy of binding. Therefore, the overall effect will lead to a 
reduction in free energy barrier of the cis–trans isomerization in the active site of the enzyme, as com-
pared to the free substrate in solution. 
In addition, our results suggest that intramolecular polarizability due to the loss of the pseudo 
double bond character of the C–N bond contributes only about −1.0 kcal/mol to the binding free energy 
of the transition state. This surprisingly small contribution from intramolecular polarizability to the free 
energy of binding amounts to a fraction of the overall expected barrier reduction. The results, therefore, 
validate the use of molecular mechanics force fields with fixed partial charges to reliably describe these 
types of systems in which the active site of the enzyme is essentially hydrophobic. 
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4      ENZYME DYNAMICS AND SOLVENT EFFECTS IN PEPTIDYL-PROLY ISOMERIZATION 
 
 
(Some parts of this chapter are verbatim as it appears in Doshi U., McGowan L. C., Tork-Ladani 
S., Hamelberg D., Resolving the complex role of enzyme conformational dynamics in catalytic function, 
2012, PNAS, 109, 5699-5704). 
4.1      Abstract 
The dynamics effects, either inherent in the system or originating from the environment, have 
been shown to play an important role in the enzyme-catalyzed reactions. However, the bulk of infor-
mation produced by extensive computational and experimental studies is far from providing a consen-
sus on the exact nature and mechanism of dynamics effects in catalysis. In the current work, extensive 
nMD(normal molecular dynamics) and aMD(accelerated molecular dynamics) simulations were carried 
out to study the effects of enzyme and solvent dynamics on the catalysis of peptidyl-prolyl isomerization 
by Cyclophilin A. The study revealed strong dynamics contributions from enzyme and solvent that 
ultimately change the kinetic behavior of chemical transformation during isomerization.  The results 
here highlight the importance of considering solvent and enzyme dynamic contributions, along with the 
energetic interactions, in studying the mechanism of action of cyclophilin A especially in realistic envi-
ronments such as cells. 
4.2      Introduction 
In addition to the enzyme-substrate energetic interactions discussed in the previous chapter, 
the dynamic contributions from enzyme and solvent are of great importance in catalysis. In the first part 
of this chapter, an introduction of enzyme and solvent dynamics effects in catalysis is presented. In addi-
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tion, a summary of Kramers rate theory and its application as a theoretical model for description of dy-
namics effects in our study of CypA-catalyzed isomerization are discussed. 
4.2.1      General features of enzyme dynamical effects in the catalysis 
Biological processes involve extremely entangled network of highly dynamic molecules and 
events that define the specific function of each biomolecule. The dynamic properties of proteins with 
the time scale in the range of picoseconds to seconds are essential for their efficient and versatile func-
tions in the intra- and extracellular environments. The key initial step in a series of events involved in 
catalysis of different biological processes by enzyme is molecular recognition. Departing from a rather 
rigid key-lock model, the “induced fit” and “fluctuation fit” were initial descriptive models of molecular 
recognition(1). These early models relied on the altered macromolecular conformations that are 
differently populated in the absence or presence of ligands. The later “conformational selection” model,  
described  the binding of enzyme and ligand in a milieu containing a pre-existing equilibrium of multiple 
macromolecular conformations, among which ligands can select the best fitting ones(1).   
Of special importance and interest is the enzyme conformational dynamics and its putative role 
in the catalysis of the biochemical reactions of various type and complexity. These conformational 
changes are present in different steps of catalysis including substrate targeting and binding, actual 
chemical action on the substrate in the active site of the enzyme, as well as the final step of product 
release(2). The studies on enzyme conformational dynamics are, therefore, important to understand the 
mechanism of action, which in turn is essential in development and optimization of any therapeutic in-
tervention in related diseases. 
Extensive experimental and computational researches have been performed to elucidate the 
exact nature and function of enzymatic motions during catalysis, Nevertheless, the results of these study 
have not succeeded to formulate a reliable consensus on the subject(2-6). The numerous studies on the 
enzyme dynamics have even led to conflicting views on the exact role of these effects during catalysis in 
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a particular system. For instance, a study on mutant dihydrofolate reductase linked the abrogated milli-
second-time-scale conformational fluctuations of enzyme active site to severely impairment in its hy-
dride transfer ability(7). On the other hand, a computational approach to the same system implied that 
dynamical knockout mutations simply change the chemical step in catalysis by changing the activation 
free energy and not by any dynamical effect(8).  The authors therefore concluded that conformational 
dynamics does not contribute to the chemical reaction, and electrostatic preorganization is the main 
factor in catalysis. These conflicting views, therefore, reflect the necessity for considering not only the 
methodology but also the semantic issues involved in probing dynamics effects in catalysis. 
The experimental data for enzyme dynamics effects are based on observation from ensemble- 
and time-averaged studies, as the temporal behavior of every atom cannot be observed directly(9). 
While this problem can be addressed by computational approaches such as MD and QM, the associated 
costs- due to the inclusion of atomistic and solvent details- limit the size and nature of the process under 
study. Nevertheless, MD and QM simulations(for reactions involving bond breaking and formation) as 
well as the inclusion of polarization effects are now widely carried out for various enzymes(10). In addi-
tion, the application of hybrid QM/MM methods in studying enzyme reactions considerably reduces the 
computational costs(11). The QM treatment of atoms involving  in the reaction while treating the rest of 
the system by MM force field have provided a very efficient way in simulation of enzymatic  reac-
tions(12). The parameterized semi-empirical methods and density functional theory are also of interest 
due to the low computational cost and possibility of extending the simulation to larger systems(9). The 
time scales, amplitudes, and energetics of motions in proteins have been studied by various NMR 
methods.  This is particularly true with the relaxation dispersion experiments which probe molecular 
motions in the microsecond to millisecond timescale quantitatively and with much higher sensitivity 
than traditional transverse relaxation experiments where clusters of motions-function couples in 
proteins are detected(13). In a work on catalytic dynamics effects by PPIases, Labeikovsky et al.(14) lo-
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cated regions of Pin1 active site that undergo conformational changes during substrate binding and 
catalytic step. It was shown that the rate of global conformational exchange detected during catalysis is 
in the same time regime as turnover rates determined by the coupled chymotrypsin assay.  Because a 
subset of the active site residues undergoes kinetically similar exchange processes even in the absence 
of substrate, the study suggested that this area is already “primed” for catalysis(14). 
    Another extensive study on a total of 117 crystal structures for ten enzymes of different sizes 
and oligomerization states revealed coupling between the catalytic loop motions and enzyme global dy-
namics(15).  A combination of principal component analysis (PCA), theoretical method, and MD simula-
tion detected the dominant conformational changes of specific loops upon substrate binding. The 
analysis suggested that robust global modes cooperatively defined by the overall enzyme architecture 
entail local components that assist in suitable opening/closure of the catalytic loop over the active 
site(15). 
On the other side of a wide spectrum of methods for studying enzyme dynamical effects lay the 
QM methods. For instance, the persistent deviation of   empirical results from semi-classical predictions 
regarding the enzymatic C-H activation has resulted in the incorporation of QM nuclear tunneling effects 
into theoretical models (16). In this regard, a study on thermophilic alcohol dehydrogenase and dihydro-
folate reductase, revealed the connection between protein conformational substates and the tunneling 
properties of the active site (16). 
4.2.2      Enzyme dynamical effects in CypA-catalyzed isomerization 
As an extensively studied enzyme of the PPIases family, Cyclophilin A has been also the subject 
of ongoing controversy over the role of enzyme dynamics in its catalytic function.  
Recent NMR relaxation experiments suggested the link between protein dynamics and PPIase 
activity of CypA (3, 17). These experiments detected motions for the backbone of several amino acid 
residues of the active site, such as  catalytically important Arg55 and Asn102 which occur only during 
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substrate turnover(3). It was shown that Arg55 experiences the same μs-ms time-scale motions as those 
of isomerization during the catalysis (17-19). As a part of conserved network of motionally coupled resi-
dues extending from surface regions to the active site, Arg55 has been identified to be critical residue 
for CypA-catalyzed isomerization(3). This direct effect of Arg55 motions in isomerization barrier crossing 
during catalysis implies, in contrast to many other enzymes, that the movement of Arg55 and not its 
rigidity are critical for this specific chemical transformation(18). Nevertheless, although MM/QM studies 
by Cui and co-workers (20) showed the important catalytic role of Arg55, but their study found no effect 
of protein motions on catalysis in a nanosecond time scale (3, 20). The authors, however, suggested that 
protein dynamics in the sub-millisecond time scale may play a role in catalysis(3). 
 Other NMR relaxation studies have also detected strong correlation between microsecond con-
formational fluctuations of the CypA active site and the microscopic rates of substrate turnover(4). The 
detected characteristic enzyme motions during catalytic transformation with frequencies corresponding 
to the catalytic turnover rates were suggested  to be already present in the free enzyme(13). The study 
suggested that these motions are intrinsic property of the enzyme that not only is present in the active 
site but also in a wider dynamic network. Based on these results the authors proposed that the pre-
existence of collective dynamics in enzymes before catalysis is a common feature of biocatalysts during 
evolution(13). 
Several computational studies have also revealed important features of CypA dynamics in free 
and enzyme-bound substrate.(21-23). MD simulations have shown that conformational dynamics of the 
active site residues of substrate-bound CypA is inherent in the substrate-free enzyme(22). During cataly-
sis, CypA interacts with its substrate via conformational selection as the configurations of the substrate 
changes during the chemical transformation. The results of the study also suggested coupling among 
enzyme-substrate intermolecular interactions, dynamics of CypA, and the chemical step(22). 
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In addition, computational studies have shown the implication of enzyme conformational dy-
namics in drug design(23). An MD analysis on dynamics of CypA active site showed that similar ensem-
bles of enzyme conformations recognize diverse inhibitors and bind different configurations of the sub-
strate(23). In addition, different nonpeptidomimetic inhibitors are recognized by enzyme ensembles 
that are similar to those that tightly bind the transition state. These results suggest that the enzyme–
substrate ensembles are more relevant in structure-based drug design for CypA than free enzyme. The 
study therefore concluded that the optimized interactions of lead compounds with the enzyme’s con-
formational ensemble similar to those bound to the substrate in the transition state could lead to more 
potent inhibitors(23). 
4.2.3      Kramers rate theory for studying dynamics effects in catalysis 
An accurate description of enzyme and solvent dynamic effects in biological processes depends 
on a realistic model that reflects all contributing factors in the system under study. Kramers rate    theo-
ry(24, 25) has proven to be an intriguing model for studying kinetic behavior in biological systems. This 
model was applied in our study of enzyme dynamics effects in the prolyl-peptidyl isomerization and, 
therefore, a summary of the model is presented here. 
 
Figure 9. One-dimensional potential model used in Kramers rate theory (From Ref 25) 
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In 1940(24), Kramers suggested a model for a chemical reaction consisting of a classical particle 
of mass M moving in a one-dimensional double-well potential U(x) (Figure 9). The coordinate of particle 
corresponds to the reaction coordinate(x) where its values at the minima of the potential, (U(x)) are xa 
and xc that denote the reactant and product states, respectively(25). These states are separated by xb at 
the maximum of U(x) which correspond to the transition state (or activated complex). All of the 
remaining degrees of freedom of both reacting and solvent molecules form a heat bath at a 
temperature T. The thermal bath creates fluctuating force, (ξ(t)) and linear damping force, (Mγẋ), where 
γ is a constant damping rate.  The motions of the particle therefore represented by Langevin equation 
as:   
ܯẌ = 	−ܷᇱ(ݔ) − 	ߛܯẋ + 	ߦ(ݐ)         (4-1) 
In the presence of strong friction (higher γ) the corresponding rate of escape from the reactant 
well is represented by Kramers equation as: 
ܭ = ఠ௢ఠ௕஽௘௙௙
ଶగ௄஻்
	exp	(ି௱ீ#
௄஻்
)        (4-2) 
where ωo and ωb are the curvatures of the reactant well and the barrier region, respectively, ΔG# 
is the free energy barrier height, and Deff  is the effective diffusion coefficient. Deff is representative of 
frictional and dynamics effects from internal or environmental origin. This means that the uncatalyzed 
and enzyme-catalyzed reactions would have different values for Deff and rates due to the disparity of 
environmental effects in free and enzyme-bound substrate.  
4.2.4      Current Study  
In the first part of the current work, we studied the role of CypA dynamics in the cis-trans isom-
erization of peptidyl-prolyl bond of the well-studied substrate analogue of CypA (Ace-AAPF-Nme). The 
effects of enzyme dynamics in CypA-catalyzed were monitored with extensive MD and aMD simulations. 
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However, due to high barrier of isomerization, a sufficient number of trans-cis transitions would not be 
observed in a standard MD trajectory of even several hundred nanoseconds. This problem posed limita-
tion in obtaining enough kinetic data in our study of enzyme dynamics effects. The MD simulations 
therefore were carried out with lower energy barriers.  
The main determinant of the energy barrier of isomerization is the V2 parameter. This parame-
ter is the force constant in the dihedral energy function of Amber force field(26): 
 ∑dihedrals	 ௏௡
ଶ
[1 + cos	(݊߱ − ߛ)]     (4-3) 
 In this equation n, ω, and γ represent the periodicity, dihedral angle, and phase angle, respec-
tively.  V2 (for which n = 2 and γ = 180°) predominantly controls the rotational barrier only around the 
peptidyl-prolyl bonds switching between cis and trans states(27). Changing V2 modifies the total poten-
tial and hence the free-energy barriers of isomerization (21).  
The reoptimized  value of V2   is 28 kcal/mol(27) which would lead to high energy barrier and a 
second-timescale isomerization. In the current work, the isomerization timescale was shifted from sec-
onds to nanoseconds by reducing V2 to lower values of 11.0, 9.0, 7.0, 5.0, 4.0, and 0 kcal/mol. For each 
value of V2, we performed individual normal MD (nMD) simulations on the free solvated substrate to 
model the uncatalyzed reaction in solution as well as on the CypA-substrate complex to model the 
catalyzed isomerization in the active site of the enzyme. In addition, the free energy profiles for the un-
catalyzed and CypA-catalyzed cis-trans isomerization for each distinct value of the rotational barrier 
were generated using umbrella sampling (Section 4.3.5). Free energies of activation (ΔG#) and the curva-
tures of the trans well (ωo and ωb) were calculated from the free energy profiles. 
 The study revealed that the dynamics of isomerization is intricately coupled to enzymatic mo-
tions resulting in a multi-exponential kinetics, contrary to a single- exponential one in the free substrate. 
The extent of the coupling between chemical step and enzyme dynamics depends on the peptidyl-prolyl 
bond barrier height and its characteristic timescale. Modeling kinetic data obtained from the survival 
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probability profiles allowed us to plot the kinetic rate versus the free energy barrier with a well-defined 
slope of 1/kBT using the overdamped region of Kramers equation (Section 4.2.3). The results showed 
that the enzyme conformational dynamics can be incorporated into the substrate’s effective diffusion 
coefficient, which turns out to be about 13 times lower in enzyme environment than in solution. 
Therefore, the enzyme conformational dynamics alter and modulate the pre-exponential kinetic factor 
and reaffirmed stabilization of the transition state as the main effect in enhancing chemical rates. 
In the above-mentioned part of the study and with an assumption of constant diffusion coeffi-
cient in Kramers rate model, the kinetic parameters for the trans to cis isomerization in the free and en-
zyme-bound substrate were calculated. The study on the isomerization in the other direction, i.e., cis to 
trans in the free and enzyme-bound substrate with the same assumption would give an overall view of 
enzyme dynamics effects on both directions. Comparison of the kinetic results with experimental data 
can further validate our computational approach in kinetic study of peptidyl-prolyl isomerization.  
The enzyme fluctuations discussed here are not themselves separated from the environment at 
which they maneuver and do their job. Picturing proteins as solvent-stripped entities does not reflect 
their real complicated dynamics and function. Extensive theoretical and experimental studies about the 
effects of solvent dynamics on the enzyme dynamic and function have been done for various processes 
involving proteins(28, 29). The results of these studies highlight the importance of solvent properties 
and its power in shifting the direction of an enzymatic reaction. 
The quest for understanding dynamical effects in CypA-catalyzed peptidyl-prolyl isomerization 
further led us to examine the solvent contributions more closely and to investigate whether the dynam-
ics of the substrate during catalysis are influenced by the dynamics of the solvent. The enzymatic mo-
tions at different timescales were shown to be coupled to the substrate dynamics during catalysis. What 
is the extent to which the solvent motions influence the dynamics of the chemical step?   
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Using different values for solvent viscosity, extensive MD simulations were carried out to exam-
ine the effects of solvent dynamics on the isomerization in the CypA-bound substrate. The results re-
vealed that the dynamics of the solvent affect the rate and kinetic behavior of substrate isomerization in 
the active site of CypA. The chemical step in the active site of the enzyme is therefore not separated 
from the fluctuations in the solvent. Of special interest is, therefore, the nature of catalysis in a more 
realistic crowded environment, for example, the cell. Enzyme motions in such complicated medium are 
subjected to different viscosities and hydrodynamic properties, which could have implications for allo-
steric regulation and function. 
4.3      Computational Method 
4.3.1      Models for studying enzyme dynamics in the trans to cis isomerization  
Free enzyme: To be consistent with previous studies on peptidyl-prolyl isomerase Cyclophilin A 
(CypA) (that employed monoprotonated CypA at His92), its X-ray structure (PDB code 1VBT, chain A) 
was modified to reflect the monoprotonation state at δ-nitrogen and neutral charge on His92. The coor-
dinates of the bound substrate Ala-Ala-Pro-Phe and water molecules were deleted from the PDB file and 
the missing first residue Methionine was added using the xleap program. After neutralizing the positive 
charges on the protein by addition of equal number of counterions, CypA was solvated in a truncated 
periodic octahedral box (having approximate dimensions of 75 × 75 × 75 Å3) with solvent placed at a 
spacing distance of up to 10 Å away from the solute unit and was filled with TIP3P water(30). An initial 
minimization of 1,000 steps with the steepest descent algorithm was carried out in which CypA was held 
with a harmonic restraining force constant (k) of 100 kcal∕mol·Å2 while the solvent was allowed to relax. 
Subsequently, two MD runs were performed: the first run for 100 ps with a k of 100 kcal∕mol·Å2 fol-
lowed by the second one for 200 ps in which k was reduced to 20 kcal∕mol·Å2. Finally, the system of 
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solvated CypA was equilibrated for 200 ps without any restraints on the protein. These steps brought 
the density and temperature of the system to approximately 1 g/mL and 300 K, respectively. 
Substrate-bound CypA: To begin with, we used the crystal structure of CypA in complex with 
the peptide HAGPIA from HIV-1 capsid protein (PDB code 1AWR, chain A). Using xleap the substrate in 
the complex was then modified to a blocked tetrapeptide Ace-Ala-Ala-Pro-Phe-Nme, as one of the most 
specific and widely studied substrates of CypA. Since the ω dihedral between Ala-Pro moiety is in the 
default trans configuration, the resulting structure was used as CypA bound to the substrate in the trans 
state (Ctrans). This complex was solvated in a truncated periodic octahedral box filled with TIP3P water 
molecules that were placed up to 10 Å away from the solute unit. The system was then subjected to the 
4-step equilibration as was done for the free enzyme (see above). Since the ω dihedral between Ala-Pro 
moiety remained in the default trans configuration (i.e., around ± 180°), the equilibrated structure was 
used as the starting configuration for standard MD simulations on CypA bound to the substrate in the 
trans state (Ctrans). To model the complex of CypA and the substrate in the transition state (CTS), the ω 
dihedral was gradually changed to 90° with restraints during an additional equilibration. During the 
equilibration and production runs the Ala-Pro ω dihedral was restrained in the transition state 
configuration using a flat-welled parabola with its flat region defined by 90° ± 5° and linear region by 90° 
± 10° with a force constant of 1000 kcal∕mol·rad2. Starting with the equilibrated structure of CTS we car-
ried out an additional short equilibration in the absence of any restraints that allowed the ω dihedral to 
achieve the cis configuration (i.e., around 0°). The resulting structure was used as the initial model for 
simulations on CypA bound to the cis isomer of the substrate (Ccis). 
Free substrate: The starting structure of the free substrate Ace-Ala-Ala-Pro-Phe-Nme was gen-
erated using the xleap program. The peptide was then solvated in a cubic periodic box with each side 
being 35 Å and filled with TIP3P water molecules. The water molecules were placed up to 10 Å away 
from the peptide and the system was subjected to minimization and equilibration. The ω bond between 
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the Ala-Pro moiety was generated in the trans configuration by default and remained in that configura-
tion throughout the equilibration phase. 
4.3.2      Molecular dynamics (MD) Simulations 
MD simulations were performed with the AMBER 10 suite of programs(26) with the modified 
version of the parm99  force field(31). We used the reoptimized parameter(27)  for the torsional force 
constant; i.e.,V2 = 28 kcal∕mol, which controls the potential energy barrier for rotation about the ω 
bond. All input files were generated using the xleap program and the crystal structures from the protein 
databank (PDB). The equilibration and production runs for each study were carried out at the NPT 
(number of atoms, pressure, and temperature are kept constant) ensemble with a constant pressure of 
1 bar and temperature of 300 K. Temperature and pressure regulation was achieved, respectively, using 
Langevin thermostat with collision frequency of 1 ps−1 and isotropic position scaling with a coupling 
constant of 1 ps for coupling to external pressure bath. Bonds involving hydrogen atoms were con-
strained using the SHAKE(32)  algorithm with a tolerance of 0.0001. Particle mesh Ewald(33) method 
was used to evaluate long-range interactions whereas short-range non-bonded interactions were 
calculated with a cutoff of 9 Å. An integration time step of 2 fs was used to numerically solve Newton’s 
equations of motion. Data was saved every 500 steps, i.e. every 1 ps. The production runs were 
performed in sets of 10 ns, each time restarting the simulation with a unique random number seed. 
While free CypA was subjected to MD for 300 ns, for each complex of CypA, i.e. Ctrans, CTS, and Ccis pro-
duction runs of 50 ns were performed. In each case, the first 10-ns data was assigned to an additional 
equilibration and hence was discarded for any further analysis. Since the activation barriers to cis-trans 
isomerization are very high; i.e., approximately 20 kcal∕mol, no transitions from trans to cis or vice versa 
were observed in the normal MD simulations of the CypA-substrate complexes. Also, throughout the 
length of the simulations the CypA-substrate complexes were found to be intact; i.e., the substrate re-
mained in the binding pocket of CypA. For CTS, the ω dihedral was restrained around 90° during the pro-
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duction runs. In addition to MD simulations on free CypA and CypA-substrate complexes, MD simula-
tions on the free substrate carried out for 50 ns. 
4.3.3      Accelerated molecular dynamics (aMD) simulations 
Extensive aMD simulations were carried out with the pmemd module that was modified in-
house for the implementation of the aMD formulation(34). aMD was employed for four different cases: 
(1) free CypA, (2) substrate-bound CypA for kinetic studies, (3) free substrate for equilibrium studies (4) 
substrate bound to CypA for equilibrium studies. For cases 1 and 2 that were aimed at speeding up the 
conformational dynamics of CypA, three different and increasing levels of acceleration were elicited by 
setting α to 64 kcal∕mol and varying E. For each level of acceleration, the production phase runs were 
carried out for 110 ns. The bias potential was applied to all the torsions of the enzyme in cases 1 and 2. 
However, in case 2, only CypA was subjected to aMD, the bound substrate was simulated with normal 
MD. For cases 3 and 4, aMD was used to increase the conformational sampling rate to observe several 
cis-trans transitions and obtain free energy profiles after applying the reweighting procedure. (35) aMD 
was carried out for the free substrate with E = 107 and α = 10 kcal∕mol in five independent runs of 260 
ns each (for a total of 1.3 μs). In the case of the substrate bound to CypA, the substrate was subjected to 
aMD while the enzyme was simulated with normal MD. Two different acceleration levels were used with 
E = 107 and α = 10 kcal∕mol, which was run for 780 ns, and with E =102 and α = 5 kcal∕mol run for 410 
ns, giving a total simulation time of 1.19 μs. For these simulations, V2 was set to the reoptimized value of 
28 kcal∕mol. The VMD program(36) was used to visualize molecules.  
4.3.4      Kinetic studies of prolyl isomerization in free and enzyme- bound substrate 
The torsional barriers were lowered to 11.0, 9.0, 7.0, 5.0, 4.0, and 0 kcal∕mol. Changing V2 modi-
fies the total potential and free energy barriers of isomerization and, therefore,  enable us to shift the 
timescale from seconds to nanosecond and to get reasonable kinetic statistics. 
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For each value of V2, normal MD simulations were carried out on the free solvated substrate to 
model the uncatalyzed reaction in solution as well as on the CypA-substrate complex to model the 
catalyzed isomerization in the active site of the enzyme.  Each run of the simulation created several 
thousand trajectories starting with the substrate in the trans well and terminated once the substrate 
escaped from the trans well and reached the transition state. 
In a different set of simulations, the CypA-bound substrate was simulated with normal MD with 
V2 set to 7.0 kcal/mol while the enzyme was subjected to three increasing levels of acceleration (Section 
4.3.3). For each case, free energy profiles projected onto the ω dihedral were calculated from umbrella 
sampling (Section 4-3-5). ΔG#, ωo, and ωb were estimated from such one-dimensional free energy pro-
files. The probability of survival S(t) in the trans well for time t or longer was then calculated from the 
distribution of dwell times, p(τ), as follows: 
ܵ(ݐ) = ∫ ܲ(߬)݀ݐାஶఛୀ௧     (4-4) 
The results were the analyzed using the DISCRETE program(37) that provides nonlinear least 
square solution of multiexponential decays without any a priori guesses for the number of exponentials 
or initial parameters. The survival probability function, S(t), was fitted to the sum of discrete multiexpo-
nential decays: 
ܵ(ݐ) = ∑ ܣ݅݁ݔ݌(−ݐ/߬݅)௡௜ୀଵ       (4-5) 
Ai and τi are amplitudes and time constants of the phase i, respectively. 
The average rate constant is: 
 ݇ = ( ଵ
ழఛவ
)	                 (4-6) 
 Where < ߬ >  is the average lifetime as: < ߬ >= 	∑ ܣ݅߬݅௡௜        (4-7)  
4.3.5      Umbrella sampling for obtaining potentials of mean force (PMF) 
67 
In order to generate the PMF’s along the ω dihedral, the cis-trans isomerization in the free and 
enzyme-bound substrate was simulated using the combination of normal MD and umbrella sam-
pling(38). 
The following set of procedures were repeated for the free substrate having different torsional 
barriers (i.e., V2) of 9.0, 7.0, 5.0, 4.0, and 0.0 kcal∕mol and for the enzyme-bound substrate with V2 = 9.0 
kcal∕mol. Umbrella sampling simulations were run in 11 separate windows, each having the same har-
monic potential restraint (i.e., force constant of 32.83 kcal∕mol·rad2 or 0.02 kcal∕mol·deg2) and ran for 1 
ns. The windows were placed every 10° along the ω dihedral starting from 80° and ending at 180°. To 
ensure that the biasing potential is harmonic everywhere the width of each window was maintained at 
360° (i.e., 180° from the position of ω where each window is placed). In addition, the distance between 
the amide proton of Phe113 and Cα of the substrate’s Pro was restrained at 11 0.5 Å by applying a 
harmonic force constant of 1000 kcal∕mol·Å2 to ensure that the substrate remained in the active site of 
CypA through the simulations. Data from each window was unbiased and combined using the rapid and 
memory efficient implementation(39) of the Weighted Histogram Analysis Method (WHAM)(40) by Alan 
Grossfield. Each PMF was finally calculated using 100 bins and a convergence tolerance of 10−6 kcal∕mol 
in the WHAM program. 
4.3.6      Calculation of the order parameters (S2) 
S2 values for backbone N-H or side-chain bond vectors were obtained from the plateau region of 
the autocorrelation functions calculated by the Ptraj module of AMBER by applying second order Legen-
dre polynomials. Order parameters were not calculated for residues that did not have amide bonds; i.e., 
the first residue and Prolines. For Prolines, an arbitrary value of 1 were assigned. 
4.3.7      Characterization of CypA dynamics 
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The distributions of side-chain dihedrals of the active site residues excluding Alanines and in-
cluded Ser99 that is located much farther from the active site were examined. Serr99 was considered 
despite the fact that it is away from the active site because it has been  shown(4) that this residue 
exhibit changes in NMR chemical shifts between two CypA conformers that are comparable to those of 
active site residues. Interconversions between conformational substates that require protein dynamics 
on timescales slower than microseconds will not be observed in finite-length (i.e. 0.3 μs) normal MD. 
Therefore, we carried out accelerated MD to increase the sampling rate, as well as the conformational 
space sampled by the free enzyme. Indeed, changes were observed in the conformational distributions 
of the side-chain dihedrals of the active site residues when the results from normal MD were compared 
to those from accelerated MD at different levels of acceleration. The side-chain dihedrals for Phe60, 
Ser99, Phe113, Leu122, His126 that essentially showed a single peak in normal MD was observed to 
populate more than one rotamer in accelerated MD. With accelerated MD Met61 also exhibited a third 
peak in addition to two existing rotamers. For the remaining residues, the number of rotamers, as ob-
served in normal MD, remained constant and showed only a redistribution of population in accelerated 
MD. In these residues, the rotameric transitions were also faster, suggesting that dynamics slower than 
the microsecond timescale was captured in accelerated MD. For ease of comparison between our study 
and recent crystallographic studies by Fraser and coworkers(41) the range of side-chain values obtained 
from MD simulations i.e. [−180° to +180°] to [0° to 360°] were rescaled by adding 360° to angles less 
than 0°. The positions of the major and minor peaks also agreed well with the X-ray data shown in Fig-
ure. (41), indicating that MD simulations sampled true conformations. These results clearly showed the 
plasticity and conformational heterogeneity present in the active site of CypA even in the absence of 
substrate(22). Performing increasing levels of accelerated MD not only extended the sampling range but 
also allowed us to identify the potentially slow timescale motions. 
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No significant difference in the backbone dihedral space sampled by the active site residues in 
the free and the substrate-bound CypA was found. Comparison of the distributions of side-chain 
dihedrals in the free and substrate-bound CypA clearly indicated that the side-chain rotamers preferred 
in the bound CypA were already sampled in the free enzyme, confirming to experimental 
observations(13, 22). There was simply a shift in the rotameric population going from the free to the 
bound CypA or from one bound state to another.  
4.3.8      Enzyme dynamical Effects in the cis to trasn isomerization 
The simulations were carried out with the cis configuration of the same substrate analogue, 
Ace–Ala–Ala–Pro–Phe–Nme, which was used for studying the kinetics of trans to cis isomerization 
(Section 4.3.1). As for CypA-substrate complex, we start with the 1.58 Å resolution crystal structure 
complex of CypA with PDB ID 1AWR. The substrate analogue in the complex was modified from HAGPIA 
to Ace–AAPF–Nme. Using xleap module in AMBER, the substrate peptide bond where changed to the cis 
state and the missing atoms were added to the system. The free peptide and enzyme-bound substrates 
with explicit TIP3P water model were solvated in cubic and octahedron box, respectively. The same pro-
cedures described in Sections 4.3.1 and 4.3.2 were carried out for minimization, equilibration and pro-
duction steps of free and enzyme-bound substrate.  During minimization and equilibration runs the Ala-
Pro ω dihedral was restrained in the cis configuration using a force constant of 1000 kcal∕mol·rad2. 
Extensive MD simulations were carried out to gather sufficient data for elucidating of kinetic pa-
rameters of cis to trans isomerization of peptidyl-prolyl bond in the free and enzyme-bound substrate.  
As in the simulation of trans to cis isomerization (Section 4.3.2), the values of reoptimized dihedral force 
constant (V2) for rotation around  peptide bond  were reduced to lower ones of 11.0, 9.0, 7.0, 5.0, 4.0, 
and 0 kcal/mol. For each value of V2, individual normal MD simulations of isomerization in free and en-
zyme-bound substrate were performed. The simulations were initialized from starting structure at cis 
well and terminated when it reach to transition state (i.e., 90°) in the clockwise direction or when the 
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substrate diffused out of the active site. After getting sufficient number of jumps to transition state, the 
probability of survival in the cis  well for time t or longer and average time constant <τ> were calculated 
from the distribution of dwell times, p(τ), as described in Section 4.3.4. 
4.3.9      Diffusion coefficient from auto-correlation functions 
To find the diffusion coefficient from the autocorrelation function, we needed to get the fluctua-
tion distribution of the peptidyl prolyl ω-bond in the trans well. These fluctuations were recorded using 
normal MD simulation in TIP3P water and with using the actual reoptimized parameter of torsional po-
tential (V2 = 28 kcal/mol) for peptidyl-prolyl ω-bond in free and enzyme-bound substrate. The proce-
dures for preparation trans states of free and CypA-bound substrate as well as the nMD simulation were 
the same as those described above (Sections 2-1-1 and 2-1-2).  
Using Ptraj module of Amber 10 suite of programs, the autocorrelation functions of fluctuation 
of the peptide bond were calculated and plotted. These fluctuations can be modeled as a special case of 
the Ornstein–Uhlenbeck (OU) process. Therefore, the tail of the autocorrelation functions were fitted to 
a single exponential curve and the diffusion coefficients were obtained from equations 4-2 and 4-3 at 
T=300 K. 
4.3.10      Solvent dynamic effects in the cis to trans isomerization 
The general procedure for measurement of solvent dynamics effects in the cis to trans peptidyl-
prolyl isomerization in the active site of CypA was the same as what described in Section 4.3.2. The only 
difference is modification of the viscosity of the solvent by altering the frequency of the Langevin 
thermostat (equation 4-1) for only water molecules while keeping the collision frequency of the rest of 
the system (substrate and CypA) at 1.0 ps-1. The TIP3P water model was used for all of the simulations. 
Individual normal MD simulations of enzyme-bound substrate were carried out for each value of solvent 
collision frequency (1, 5, 10, 20, and 40   ps-1) and V2 value of 7.0 kcal/mol. The simulations were 
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initialized from starting structure at the cis well and terminated when it reach to the transition state 
(i.e., 90°) in the clockwise direction or when the substrate diffused out of the active site.  After getting 
sufficient number of the jumps to transition state, the survival probabilities and the average time con-
stant corresponding to each value of solvent collision frequency were calculated as described in Section 
4.3.2. 
4.4      Results and discussion 
4.4.1      Enzyme dynamicaleffects in trans to cis isomerization 
Extensive MD and aMD simulations were carried out to examine the effects of enzyme dynamics 
in CypA-catalyzed isomerization of peptidyl-prolyl bond. However, due to high energy barrier of isomeri-
zation, sufficient number of trans to cis transitions would not be observed in a standard MD trajectory of 
even several hundred nanoseconds. The MD simulations therefore were carried out with lower energy 
barrier using reduced values for torsional constant (V2 parameter in Amber force field), as described in 
Section 4-2-4. 
Extensive studies have revealed that enzyme fluctuations are influential in substrate recognition 
and binding as well as product release.(42) What about their role in the actual chemical step during ca-
talysis? We addressed this question in respect to the cis-trans isomerization of the peptidyl-prolyl bond 
by CypA to see if CypA fluctuations can actually change the kinetics of the chemical step (isomerization)?  
Comparing the survival probabilities in the trans well (Figure 10) reveals contrasting feature of 
isomerization in the free and enzyme-bound substrate. In both cases, increasing energy barrier (torsion-
al potential parameter, V2) will increase the time constant of decay of survival probabilities (Table 1). In 
the free substrate, a single-exponential decay of survival probability of substrate in trans well is ob-
served. Interestingly, with the same energy barrier, the survival probabilities of enzyme-bound substrate 
in trans well show a multi-exponential decay. This observation clearly revealed the effect of environ-
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ment (enzyme in this case) on the kinetic behavior of the isomerization. This means that the enzyme 
motions have coupled to substrate dynamics and, therefore, affect the chemical step during catalysis. 
Further evidence supporting the notion of the coupling between the dynamics of the enzyme 
and isomerization in the substrate came from a second approach, accelerating the motions of only en-
zyme, CypA, by accelerated molecular dynamics. The aMD resulted in faster CypA dynamics by an 
increase in its conformational plasticity as revealed by the shift of backbone and side chain order 
parameters to lower values, as well as conformational heterogeneity at the active site of free 
enzyme(22) (Figures 11 and 12). 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Effects of enzyme dynamics on isomerization. Decay of probability of.  
Figure 10. Effects of enzyme dynamics on isomerisation. Decay of probability of survival in the trans well as a 
function of time obtained from nMD simulations of (A) Uncatalyzed and (B) isomerization with V2 set to 11.0 
(cyan), 9.0 (red), 7.0 (blue), 5.0 (yellow), 4.0 (green), and 0.0 (magenta) kcal/mol. Continuous lines are fits to 
single exponential in (A) and multiexponential functions in (B). (Inset to C) Plots of survival probability func-
tions on an extended timescale when V2 = 7.0, 9.0 and 11.0 kcal∕mol.  
73 
 
Figure 11. Effects of accelerating CypA dynamics on prolyl isomerization in the substrate. Distribution of 
order parameters (S2) obtained from (A) normal MD and (B) accelerated MD of free CypA using the 
highest level of acceleration. Fluctuations with the largest amplitudes are indicated by the smallest S2 
(red) while those with the smallest amplitudes are depicted with the largest S2 (blue). (C) Decay of 
probability of survival in the trans well as a function of time when V2 = 7 kcal∕mol.  Shown are the 
isomerization kinetics in the free substrate (cyan, S) when subjected to nMD and the enzyme-bound 
substrate when CypA was subjected to nMD (blue, ES) as well as aMD at the lowest (orange, A1), 
intermediate (dark red, A2), and the highest (dark green, A3) level of acceleration. Continuous black 
lines are mono- or multiexponential fits. 
The simulations here also confirmed recent experimental observations (13, 43) that enzyme 
conformational dynamics in CypA takes place over a broad range of timescales even in the substrate-
free state (Figure 12) 
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Figure 12. Accelerated MD increases the dynamics in CypA active site. Structure of CypA (gray) is shown 
with its active site residues in stick representation. The ten active site residues are colored (see color 
scale) according to S2 values obtained from (A) nMD and (B) aMD for their specific side-chain bond 
vectors indicated in brackets as follows: Arg55(NE-CZ bond), Phe60(CA-CB bond), Met61(CG-SD bond), 
Gln63(CG-CD bond), Ala101(CA-CB bond), Asn102 (CG-ND2 bond), Ala103(CA-CB bond), Phe113(CA-CB 
bond), Leu122(CG-CD1 bond), His126(CA-CB bond). 
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Table 1. Free energy barriers (∆G#), diffusion coefficient (Deff) and time constants (τ) for the uncatalyzed 
and catalyzed trans to cis isomerization with different torsional barriers (V2) 
 
 
It was shown that accelerating CypA dynamics changes the kinetics of prolyl isomerization in the 
bound substrate, resulting in a faster decay of the survival probability (Figure. 11 C). The results showed 
a gradual speed up in isomerization as the extent of acceleration of CypA motions was increased (Table 
I).  The corresponding faster decay of the survival probability of the substrate in the trans well reaffirms 
the intricate coupling between enzyme dynamics and fluctuations in the substrate during catalysis. 
4.4.2      Modeling enzyme dynamical effects with Kramers rate theory 
 V2 
(Kcal/mol) 
∆G# 
(Kcal/mol)  
<τ> 
(ns) 
Deff 
(deg2/s) 
∆G# 
(Kcal/mol) 
<τ> 
(ns) 
Deff 
(deg2/s) 
nMD 0 0.81 0.05 18.1 * 1014  0.01 1.37*1014 
nMD 4 2.3 0.28 18.1 * 1014  0.07 1.37*1014 
nMD 5 3.16 0.54 18.1 * 1014  0.16 1.37*1014 
nMD 7 3.93 2.48 18.1 * 1014 0.99 0.50 1.37*1014 
nMD 9 5.57 16.11 18.1 * 1014 2.31 1.35 1.37*1014 
nMD 11 7.42 61.65 18.1 * 1014 3.49 6.24 1.37*1014 
aMD 28 20.0 1.22 * 1011 18.1 * 1014 10.74 2.7*105  
aMD I 7    2.09 0.26 5.44*1014 
aMD II 7    2.37 0.14 13.36*1014 
aMD III 7    2.7 0.09 31.23*1014 
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Kramers rate theory in the high-friction region(24) (Section 4-2-3, Figure 9) was then used to es-
timate the substrate relative effective diffusion, Deff, in the catalyzed and uncatalyzed isomerization pro-
cesses. The kinetic data (k, ΔG#,ωo and ωb) for each rotational barrier were fitted to the logarithm form 
of Kramer equation: ln ቀ ௞
ఠ௢ఠ௕
ቁ = ln ቀ ஽௘௙௙
ଶగ௞஻்
ቁ−
ଵ
௄஻்
߂ܩ#      (4-8) 
The plots of ln	( ௄
ఠ௢ఠ௕
)  vs. ΔG# with a well-defined slope of 1/kBT were created and the effective 
diffusion coefficients, Deff  were then calculated from the y-intercept of these plots (Figure 13 and Table 
1). Generally, a changes in the free energy barrier (ΔG#) or the kinetic prefactor (which is manifested in 
Deff) can influence the rate of isomerization. Several environmental factors including solvent viscosity 
and dynamics, enzyme internal friction and dynamics as well as energetic roughness in the aqueous en-
vironment and the enzyme’s active site are included in Deff. This means that in the uncatalyzed and cata-
lyzed reactions different values for Deff of free and enzyme-bound substrate would be observed.  
Comparison of Deff in catalyzed and uncatalyzed isomerization indeed showed such influence; 
Deff is decreased for the isomerization in the enzyme. Enzymatic motions effectively limit substrate diffu-
sion and reduce the anticipated increase in isomerization rate if only the reduction in ΔG# is considered. 
A rate enhancement of approximately 4.5 × 105 times was observed for enzyme-catalyzed isomerization, 
using the Kramers rate theory, which is in excellent agreement with experimentally observed speedup of 
~105(44). Since the diffusion coefficient has actually been reduced in enzyme, the main factor in rate 
enhancement in catalysis is therefore attributed to decreasing in free energy barrier. As discussed in 
chapter 3 preferential binding of transition state, compared to binding of the enzyme to cis or trans re-
duces the free energy barrier of isomerization. The results here therefore reaffirm the stabilization of 
transition state as the main factor in rate speed-up by cyclophilin A. 
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Figure 13.  Comparison of peptidyl-prolyl isomerization kinetics in the free and the enzyme-bound sub-
strate. Kramers plots are shown in the form of ln(k∕ωoωb) vs. ΔG#.(A) Normal MD data points for uncata-
lyzed (open blue circles) and catalyzed (filled blue circles) isomerization when V2= 0, 4, 5, 7, 9, and 11 
kcal∕mol. (B) Same plot as in (A). For clarity, only data points from normal MD corresponding to V2=7.0 
kcal∕mol are shown. Also plotted are the data points for catalyzed from accelerated MD when the low-
est (violet), intermediate (magenta), and the highest (red) level of acceleration are applied on CypA. All 
continuous lines are linear fits with slope=1∕kBT. (C) Same plot as in (A) with linear fits that are 
extrapolated to higher free energy barriers. Data points for uncatalyzed (open orange circle) and 
catalyzed (filled orange circle) are shown when the reoptimized V2=28 kcal∕mol was used in accelerated 
MD and assumed to follow the corresponding linear trends (i.e., red and green lines, respectively). Gray 
dashed lines above the red and below the green lines (with the same slope=1∕kBT) represent illustrative 
kinetic trends for catalyzed isomerization in CypA mutants with faster and slower dynamics, respectively 
than the wild-type enzyme. Horizontal and vertical dashed lines with arrows depict reduction in free 
4.4.3      Diffusion coefficients from autocorrelation functions 
A comparison of values of Deff obtained from autocorrelation function and those from Kramer 
rate theory can be used to validate applying Kramer model in describing the kinetics of peptidyl-prolyl 
isomerization in the type of systems studied in this work. 
From a dynamic perspective, the high friction environment of the biomolecular system make the 
inertia component become less significant compared to that of diffusion and, therefore, the molecular 
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motions tend to obey the Brownian dynamics.  The diffusive properties along a degree of freedoms of 
such system can then be elucidated from the autocorrelation function of the velocity.  Here we used a 
previously(45) developed model for description of the changes in peptidyl-prolyl ω-bond as a Brownian 
motion on an effective one-dimensional (1D) energy profile, U(ω). These Brownian motions in a harmon-
ic potential can be modeled as a position space analog of the Ornstein−Uhlenbeck (OU) process(46), 
with 
ܷ(߱) = ௄
ଶ
(߱ − ߛ)2       (4-7)  
Here, K is the effective force constant and γ ≈ 180o. The effective diffusion coefficient of free and 
enzyme-bound substrate can be then calculated from the autocorrelation function of ω-bond as:  
ழఠ(଴)ఠ(௧)வ
ழఠଶவ
= exp	(−ݐܦ݂݂݁ܭ/݇ܤܶ)        (4-8) 
Where  
              < ߱2 > = kBT/K     (4-10) 
The diffusion coefficients of the free and enzyme-bound substrate in the trans well were there-
fore obtained from these autocorrelation functions (Figure 14). The slower the decay, the smaller is the 
diffusion coefficient. As it turned out, the effective diffusion in the active site environment of CypA is 
about 14  times smaller than that of the free substrate in solution, in good agreement with the observed 
around 13 times smaller Deff  estimated during barrier crossing using the Kramers rate theory. The 
observation, therefore, validates our kinetic approach and reaffirms the reliability of Kramer rate model 
for kinetic description of these biological systems.  
 
 
 
 
 
Figure 14. The autocorrelation function of peptide ω-bond angle in free (red) and                                                                   
enzyme-bound substrate (black). 
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4.4.4      Enzyme dynamical effects in other direction: cis to trans isomerization 
Extensive normal MD with the cis isomer of the same substrate as above (Ace-AAPF-Nme) and 
same values of reduced torsional energy parameter, V2, for -Ala-Pro- ω bond were carried out. Again, 
using the lowered torsional parameter led overcoming the high energy barriers and more jumps to tran-
sition state from which the isomerization kinetics were extracted. Figure 15 shows the profiles for the 
decay of survival probability function, S(t) in the cis well,  for catalyzed and uncatalyzed isomerization.  
 
Figure 15. Effects of enzyme dynamics on isomerization. Decay of probability of survival in the trans well 
as a function of time obtained from normal MD simulations of (A) Uncatalyzed and (B) isomerization 
with V2 set to 11.0 (cyan), 9.0 (red), 7.0 (blue), 5.0 (yellow), 4.0 (green), and 0.0 (magenta) kcal/mol. 
Continuous lines are fits to a single exponential in (A) and multiexponential functions in (B) 
 
These figures clearly show the sharp contrast between single and multiexponential decay of sur-
vival probability function in free and enzyme-bound substrate respectively. The single-exponential decay 
of survival probability function in free substrate indicates the lack of or very weak coupling between 
substrate dynamics and fluctuation in the solvent. On the other hand, the multiexponential behavior in 
enzyme-bound substrate revealed a strong coupling between the dynamics of chemical step and its en-
vironment. The reduction of the torsional barrier height shifted the isomerization timescale from milli-
second to nanosecond, approaching to the enzyme fluctuations timescale. Therefore, a coupling be-
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tween enzyme and substrate dynamics at different levels can be developed. The extent of these dynam-
ics associations and resulting changes in the isomerization kinetics depend on the applied torsional bar-
rier. The multiexponential decay of survival probability in the cis well is similar to that of trans isomer. 
Therefore, coupling between enzymatic motion and chemical steps can be observed in both isomeriza-
tion directions regardless of starting isomer. 
 
Table 2. Comparison of the ratios of the rate constant of cis to trans over rate constant of trans to cis 
(kcis to trans /ktrans to cis)  isomerization in the free and enzyme-bound substrate with different torsional 
energy parameter, V2. 
 
 kcis to trans /ktrans to cis 
V2 free substrate enzyme-bound substrate 
0 5.5 0.13 
4 2.3 0.37 
5 2.4 0.58 
7 3 0.99 
9 5 1.0 
11 2.5 0.7 
 
Table 2 summarizes the ratios of rate constant of the cis to trans over rate constant of trans to 
cis isomerization (kcis to trans /ktrans to cis) in free and enzyme-bound substrate with different torsional energy 
parameter, V2. In the free substrate, the ratio of rate constant of cis to trans over that of trans to cis is 
greater than 1 for all V2 values. In contrast, this ratio is less than 1 in enzyme-bound complex again for 
all values of V2. These results can be explained by the free energy profile of the isomerization along the 
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substrate ω bond. In the free substrate, the cis isomer has slightly higher energy than trans, leading to a 
smaller energy barrier to transition state. In contrary, the better binding of the enzyme to the cis stabi-
lizes this state relative to trans that lead to increase in the survival time in cis well and higher time con-
stant of cis-trans isomerization in the enzyme-bound substrate. 
Averaging over listed ratios in Table 2  yields to an average ratio (kcis to trans /ktrans to cis) of 3.45 in 
free and 0.64 in enzyme-bond substrate. The results here are interestingly in agreement with the 
experimental data for the ratio of rate constant of cis to trans (k cis to trans.exp ) over the rate constant of 
trans to cis (ktrans to cis.exp). Experimental data from dynamic NMR studies on the kinetics of the same sys-
tem have shown a Kcis to trans.exp/ktrans to cis.exp of 3 and 0.69 for isomerization in free and enzyme-bond sub-
strate respectively. These results here therefore further validate the computational approach applied in 
this work for studying the kinetics of peptidyl-prolyl isomerization. 
4.4.5      Solvent dynamical effects in catalysis 
To examine the effects of the solvent dynamics, extensive MD simulations of the kinetics of the 
cis to trans peptidyl-prolyl isomerization in the active site of CypA, using different viscosity of the sol-
vent, were carried out. Based on the Stokes’ law, the collision frequency (γ) in the Langevin dynamics 
(Section 4.2.3)   is directly related to the viscosity (η) as:  
ߛ = ଺గఎఈ
௠
          (4-11) 
Where m and α are the particle mass and hydrodynamic radius, respectively.  
The kinetic rate of going over the isomerization barrier is obtained from the survival probabili-
ties in Figure 16. The TIP3P water(30) model was used for all the simulations, and the viscosity was 
modified by altering the collision frequency of the Langevin thermostat for only water molecules while 
keeping the collision frequency of protein and substrate at 1.0 ps-1. The rates were obtained at five dif-
ferent viscosities of solvent, that  is, collision frequencies of 1, 5, 10, 20, and 40 ps-1. As expected, a mul-
tiexponential kinetic behavior was observed again for the isomerization process of the substrate in the 
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enzyme-bound complex with different solvent viscosity (Figure 16). Interestingly, the solvent dynamics 
(represented by the value of collision frequency) appears to affect the dynamics of the enzyme, which 
ultimately changes the kinetic behavior of the isomerization process. The substrate in the active site of 
the enzyme, therefore, “feels” the solvent fluctuations and the chemical step is not separated from the 
dynamics coupling between enzyme and solvent.  
The observation here is in the line with previous studies regarding solvent effects on protein 
motions and function (28, 29, 47). For instance, a study on Raman and neutron scattering spectra of ly-
sozyme showed that the protein fluctuations follow the dynamics of the solvents glycerol and treha-
lose(48). The enzyme’s fast conformational fluctuations and low-frequency vibrations as well as their 
temperature variations were shown to be very sensitive to the solvent behavior. Based on this study the 
authors concluded that solvent dynamics control protein dynamics and activity and therefore  protein 
appears to be a ‘‘slave’’ of the solvents on the picosecond time scale(48).  
 
Figure 16.  Solvent dynamical effects on the isomerization kinetics of enzyme-bound substrate. (A) De-
cay of probability of survival in the cis well as a function of time using different solvent collision frequen-
cy (γ) set to 1, 5, 10, 20 and 40 ps-1 (B) The average survival time in the cis well as a function of solvent 
collision frequency (γ). 
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A series of interesting studies by  Frauenfelder et al. on myoglobin examined dynamic effects 
originating from the hydration shell as well as fluctuations in the bulk solvent(47, 49-51). These studies 
showed that protein motions (and therefore their functions) can be slaved or nonslaved to the solvent 
dynamics. While nonslaved motions (such as bond formation) are independent of the solvent fluctua-
tions, the rates of slaved motions are proportional to the fluctuation rate of the solvent.  For instance, it 
was shown that large-scale protein motions, such as the exit of a ligand from the protein interior, follow 
the dielectric changes in the bulk solvent. On the other side, the fluctuations in the hydration shell con-
trol fast motions of the protein (51). Solvent is therefore not a passive observer in the biochemical pro-
cesses; its motions dominate a broad range of biomolecular dynamics and function, including conforma-
tional fluctuations, relaxations, and catalysis.  
Hare, as shown in Figure 16B, the rate of peptidyl-prolyl isomerization in the active site of CypA 
is a function of the solvent viscosity; the higher the viscosity, the slower the rate. This observation is of 
special interest for studying the nature of catalysis in more realistic crowded environment, for example, 
the cell. Understanding the real kinetics of biological processes, by considering the effects of cell viscosi-
ty, is of great importance. The hydrodynamic properties of the intracellular matrix control the diffusion-
mediated cellular processes, such as metabolism and signaling as well as many treatment procedures 
including drug delivery(52).  
The viscosity effects have been also studied on the photochromism properties of a fluorescent 
protein(53). Kao et al. recently studied the environmental dependence of photochromism in Dronpa(a 
fluorescent protein) which exhibits a unique capability of reversible light-regulated on-off switching(53). 
They found that the photoswitching kinetics of the chromophore inside Dronpa is actually slowed down 
by increasing medium viscosity outside Dronpa. This finding is a special example of a fluorescent protein 
where the hydrodynamics of the environment affects the internal chromophore. In addition, the spatial 
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distribution of microviscosity in the live cells was shown to be reflected in the kinetic behavior of bio-
chemical processes in different parts of the cell(53). 
4.5      Summary  
In the current study, extensive MD and aMD simulations were carried out to investigate the dy-
namics effects of Cyclophilin A and solvent on the kinetics of peptidyl-prolyl isomerization during cataly-
sis. Due to high energy barrier of isomerization and difficulties with collecting sufficient data, the simula-
tions were carried out with reduced torsional energy barriers. The study revealed strong coupling be-
tween the isomerization kinetics and dynamics contributions from both enzyme and solvent. The single-
exponential kinetics of isomerization in the free substrate changed to a multi-exponential behavior in 
the active site of the enzyme. Applying Kramer rate model to interpret kinetic data revealed that the 
effects of enzyme motions can effectively incorporated into the substrate diffusion coefficient. It was 
shown that substrate diffusion coefficient is about 13 times less in the enzyme-bound substrate com-
pared to that of free substrate. The observation here, therefore, reaffirms the transition state 
stabilization, and not dynamics effects, as the main factor in more than 105  rate speed-up in 
isomerization by cyclophilin A. The excellent agreements between calculated and experimental values 
for rate speed-up by enzyme validate our approach in application of Kramers rate theory in modelling 
enzyme dynamics effects. In addition, changing the solvent viscosity was show to alter the kinetic behav-
ior and rate of isomerization in enzyme-bound substrate. The results here highlight the importance of 
environment properties in kinetic behavior of peptidyl-prolyl isomerization. This realization is especially 
of interest for realistic study of the isomerization in different physiological and pathological settings.   
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5      CONCLUDING REMARKS AND OUTLOOK 
An astonishingly interlaced network of energetic and dynamic effects drives enzyme catalysis. 
The exploration of the conformational space of a substrate analogue of CypA revealed that the enzyme-
substrate interactions are sensitive to the configuration of the substrate. Preferential binding of the 
transition state makes stabilization of the transition state as the major player in the speedup of the 
isomerization reaction. The conclusion here is in contrast with previously suggested mechanisms that 
could not justify the more than five order of magnitude enhancement in peptidyl-prolyl cis-trans isomer-
ization by CypA.  
Our results also suggested that the loss in conformational entropy at the transition state relative 
to the cis and trans states of the free substrate is decreased in the complex. This relative positive con-
formational entropy favorably contributes to the free energy of stabilizing the transition state by CypA. 
The relatively small contribution from intramolecular polarizability, due to loss of double-bond character 
of the peptidyl prolyl bond, allows the use of fixed-charge model for a reasonable description of these 
types of systems. In addition, it was shown that the substrate dynamics and therefore isomerization ki-
netics are strongly coupled to the enzyme motions. This means that in addition to substrate recognition 
and product release, the enzymatic motions affect the actual chemical step during catalytic isomeriza-
tion. These enzyme-substrate dynamics coupling are in turn buckled to solvent fluctuations that alter 
the kinetic behavior and rate of isomerization.  
Further studies on CypA dynamics effects in catalysis can be directed to testing isomerization in 
actual physiological targets of CypA, such as HIV capsid and Interleukin-2 tyrosine kinase (Itk). Taking to 
account CypA dynamics effects during catalysis can provide invaluable information for designing CypA 
inhibitors in numerous pathological conditions.  More studies involving CypA can also be directed to un-
derstanding environmental effects on the catalytic action of CypA. How can the cellular environment 
affect the dynamic behavior and function of CypA in different cells? How does the changing viscosity in 
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different parts of the cell alter the kinetics of CypA-catalyzed peptidyl-prolyl isomerization and its sub-
sequent signaling pathways?  
 In addition, although the intramolecular polarization was shown to have no considerable effect 
on binding energy of our system, the application of a fixed-charge model for various molecular systems 
should be examined carefully. This is especially true for highly sensitive systems with ionizable residues 
and metals where even smallest fluctuation can lead to large structural and dynamics alterations in mol-
ecule. The fixed-charge model can be therefore utilized in the simulation of less sensitive systems such 
as binding in hydrophobic active site.  
